JEADV ARTICLES

In line with the ongoing international research efforts to understand COVID-19, JEADV is committed to disseminating relevant and practical information for healthcare providers and patients. We are focusing on the implications of the novel coronavirus for dermatology and venereology. All featured articles in the JEADV COVID-19 Special Forum are freely available online.

 

JEADV COVID-19 Special Forum

Categories: General

Pitfalls of possible reporting of same patients with COVID-19 in various dermatology journals

Kluger N.



J Eur Acad Dermatol Venereol. 2020 Jun 3. doi: 10.1111/jdv.16690.

Categories: General

SARS-CoV, Mers-CoV and Covid-19: : what differences from a dermatological viewpoint?

Rongioletti F.



J Eur Acad Dermatol Venereol. 2020 Jun 11. doi: 10.1111/jdv.16738.

Categories: General

Position statement of the European Academy of Dermatology and Venereology Task Force on Quality of Life and Patient Oriented Outcomes on quality of life issues in dermatologic patients during the COVID-19 pandemic

Chernyshov PV, Tomas-Aragones L, Augustin M, Svensson A, Bewley A, Poot F, Szepietowski JC, Marron SE, Manolache L, Pustisek N, Suru A, Salavastru CM, Blome C, Salek MS, Abeni D, Sampogna F, Dalgard F, Linder D, Ewers A, Finlay AY.



J Eur Acad Dermatol Venereol. 2020 Jun 4. doi: 10.1111/jdv.16720.

Categories: General

Anti-androgens may protect against severe COVID-19 outcomes: results from a prospective cohort study of 77 hospitalized men

Goren A, Wambier CG, Herrera S, McCoy J, Vaño-Galván S, Gioia F, Comeche B, Ron R, Serrano-Villar S, Ramos PM, Cadegiani FA, Kovacevic M, Tosti A, Shapiro J, Sinclair R.



J Eur Acad Dermatol Venereol. 2020 Sep 25. doi: 10.1111/jdv.16953.

Categories: General

Androgen Receptor Genetic Variant Predicts COVID-19 Disease Severity: A Prospective Longitudinal Study of Hospitalized COVID-19 Male Patients

McCoy J, Wambier CG, Herrera S, Vaño-Galván S, Gioia F, Comeche B, Ron R, Serrano-Villar S, Iwasiow RM, Tayeb MA, Cadegiani FA, Mesinkovska NA, Shapiro J, Sinclair R, Goren A.



J Eur Acad Dermatol Venereol. 2020 Sep 25. doi: 10.1111/jdv.16956.

Categories: General

SARS-CoV-2 spike protein in a chilblain-like skin lesion is present in both endothelial and eccrine cells

T. Gambichler, J. Reuther, M. Stücker, R. Stranzenbach, C. Torres‐Reyes, R. Schlottmann, W.E. Schmidt, R. Hayajneh, A. Sriram, J.C. Becker



J Eur Acad Dermatol Venereol. 2020 Sep 25. doi.org/10.1111/jdv.16970

Categories: General

Cross-country comparisons of Google searches for chilblains before and during the COVID-19 pandemic



Categories: General

Not all that glitters is COVID-19: a case-series demonstrating the need for histopathology when skin findings accompany SARS-CoV-2 infection

A Barrera-Godínez, S Méndez-Flores, M Gatica-Torres, A Rosales-Sotomayor, KI Campos-Jiménez, DM Carrillo-Córdova, MC Durand-Muñoz, GL Mena-Hernández, YK Melchor-Mendoza, AL Ruelas-Villavicencio, A García-Irigoyen, GA Acatitla-Acevedo, S Toussaint-Caire, J Domínguez-Cherit



J Eur Acad Dermatol Venereol. 2021 May 20 com/doi/10.1111/jdv.17381

Categories: General

SARS-CoV-2: skin diseases, mask wearing and unpleasant sensations

B Cribier, C Taieb, M Saint Aroman, J Shourick



J Eur Acad Dermatol Venereol. 2021 May 20 com/doi/10.1111/jdv.17380

Categories: General

Describing the burden of the COVID-19 pandemic in people with psoriasis: findings from a global cross-sectional study

SK Mahil, M Yates, ZZN Yiu, SM Langan, T Tsakok, N Dand, KJ Mason, H McAteer, F Meynell, B Coker, A Vincent, D Urmston, A Vesty, J Kelly, C Lancelot, L Moorhead, H Bachelez, F Capon, CR Contreras, C De La Cruz, P Di Meglio, P Gisondi, D Jullien, J Lambert, L Naldi, S Norton, L Puig, P Spuls, T Torres, RB Warren, H Waweru, J Weinman, MA Brown, JB Galloway, CM Griffiths, JN Barker, CH Smith, On behalf of the PsoProtect study group



J Eur Acad Dermatol Venereol. 2021 Jun 17 com/doi/10.1111/jdv.17450

Categories: General

Changes in the incidence of contagious infectious skin diseases after the COVID-19 outbreak

E.J. Chun,J.K. Kim,S.Y. Yang,S.S. Kim,C.W. Kim



J Eur Acad Dermatol Venereol. 2021 Sep 6 com/doi/10.1111/jdv.17640

Categories: General

Estimating the incidence of Cutaneous COVID-19 reactions on the general population in a territorial setting

C. Zengarini,A. Guglielmo,M. Giovani,C. Preci,E. Dika,B.M. Piraccini,A. Pileri



J Eur Acad Dermatol Venereol. 2022 Jan 26 doi.org/10.1111/jdv.17970

Categories: General

Prevalence and patterns of cutaneous manifestations in 1245 COVID-19 patients in Japan: a single-centre study

T. Sugai,Y. Fujita,E. Inamura,Y. Maya,S. Shimizu



J Eur Acad Dermatol Venereol. 2022 Mar 11 doi.org/10.1111/jdv.18062

Categories: Guidelines and recommendations

European Task Force on Atopic Dermatitis (ETFAD) statement on severe acute respiratory syndrome coronavirus 2 (SARS‐Cov‐2)‐infection and atopic dermatitis.

Wollenberg A, Flohr C, Simon D, Cork MJ, Thyssen JP, Bieber T, de Bruin-Weller MS, Weidinger S, Deleuran M, Taieb A, Paul C, Trzeciak M, Werfel T, Seneschal J, Barbarot S, Darsow U, Torrelo A, Stalder JF, Svensson Å, Hijnen D, Gelmetti C, Szalai Z, Gieler U, De Raeve L, Kunz B, Spuls P, von Kobyletzki LB, Fölster-Holst R, Chernyshov PV, Cristen-Zaech S, Heratizadeh A, Ring J, Vestergaard C



J Eur Acad Dermatol Venereol. 2020 Mar 29. doi: 10.1111/jdv.16411.

Categories: Guidelines and recommendations

European Task Force on Contact Dermatitis statement on coronavirus 19 disease (COVID-19) outbreak and the risk of adverse cutaneous reactions.

Balato A, Ayala F, Bruze M, Crepy MN, Gonçalo M, Duus Johansen J, John SM, Pigatto P, Raimondo A, Rustemeyer T, Schuttelaar MA, Svedman C, Aerst O, Uter W, Wilkinson M, Gimenez-Arnau A.



J Eur Acad Dermatol Venereol. 2020 Apr 30. doi: 10.1111/jdv.16557.

Categories: Guidelines and recommendations

Expert recommendations for the management of autoimmune bullous diseases during the COVID-19 pandemic.

Kasperkiewicz M, Schmidt E, Fairley JA, Joly P, Payne AS, Yale ML, Zillikens D, Woodley DT.



J Eur Acad Dermatol Venereol. 2020 Apr 25. doi: 10.1111/jdv.16525.

Categories: Guidelines and recommendations

Management of primary cutaneous lymphoma patients during COVID-19 pandemic: EORTC CLTF guidelines.

Papadavid E, Scaribrick J, Ortiz Romero P, Guaglino P, Vermeer M, Knobler R, Stadler R, Bagot M.



J Eur Acad Dermatol Venereol. 2020 May 16. doi: 10.1111/jdv.16593.

Categories: Guidelines and recommendations

European Task Force on Atopic Dermatitis: position on vaccination of adult patients with atopic dermatitis against COVID‐19 (SARS‐CoV‐2) being treated with systemic medication and biologics

J.P. Thyssen C. Vestergaard S. Barbarot M.S. de Bruin‐Weller T. Bieber A. Taieb J. Seneschal M.J. Cork C. Paul C. Flohr S. Weidinger M. Trzeciak T. Werfel A. Heratizadeh U. Darsow D. Simon A. Torrelo P.V. Chernyshov J.‐F. Stalder C. Gelmetti Z. Szalai Å. Svensson L.B. von Kobyletzki L. De Raeve R. Fölster‐Holst S. Christen‐Zaech D.J. Hijnen U. Gieler J. Gutermuth C. Bangert P.I. Spuls B. Kunz J. Ring A. Wollenberg M. Deleuran



J Eur Acad Dermatol Venereol. 2021 Feb 15 doi.org/10.1111/jdv.17167

Categories: Guidelines and recommendations

Updated international expert recommendations for the management of autoimmune bullous diseases during the COVID-19 pandemic

M. Kasperkiewicz E. Schmidt M. Amagai J.A. Fairley P. Joly D.F. Murrell A.S. Payne M.L. Yale D. Zillikens D.T. Woodley



J Eur Acad Dermatol Venereol. 2021 Mar 2 doi.org/10.1111/jdv.17207

Categories: Guidelines and recommendations

Position statement of the EADV Melanoma Task Force on recommendations for the management of cutaneous melanoma patients during COVID-19

M. Arenbergerova A. Lallas E. Nagore L. Rudnicka A. Forsea M. Pasek F. Meier K. Peris J. Olah C. Posch



J Eur Acad Dermatol Venereol. 2021 Mar 29 doi.org/10.1111/jdv.17252

Categories: Cutaneous manifestations of COVID-19

Cutaneous manifestations in COVID‐19: a first perspective.

Recalcati, S.



J Eur Acad Dermatol Venereol. 2020 Mar 26. doi: 10.1111/jdv.16387.

Categories: Cutaneous manifestations of COVID-19

Comment on: Cutaneous manifestations in COVID-19: a first perspective. Safety concerns of clinical images and skin biopsies.

Fernandez-Nieto D, Ortega-Quijano D, Segurado-Miravalles G, Pindado-Ortega C, Prieto-Barrios M, Jimenez-Cauhe J.



J Eur Acad Dermatol Venereol. 2020 Apr 15. doi: 10.1111/jdv.16470.

Categories: Cutaneous manifestations of COVID-19

Comment on "Cutaneous manifestations in COVID-19: a first perspective " by Recalcati S.

Hedou M, Carsuzaa F, Chary E, Hainaut E, Cazenave-Roblot F, Masson Regnault M.



J Eur Acad Dermatol Venereol. 2020 Apr 21. doi: 10.1111/jdv.16519.

Categories: Cutaneous manifestations of COVID-19

Cutaneous manifestations in COVID-19: a new contribution.

Estébanez A, Pérez-Santiago L, Silva E, Guillen-Climent S, García-Vázquez A, Ramón MD.



J Eur Acad Dermatol Venereol. 2020 Apr 15. doi: 10.1111/jdv.16474.

Categories: Cutaneous manifestations of COVID-19

COVID-19 and cutaneous manifestations.

Mungmungpuntipantip R, Wiwanitkit V.



J Eur Acad Dermatol Venereol. 2020 Apr 15. doi: 10.1111/jdv.16483.

Categories: Cutaneous manifestations of COVID-19

A distinctive skin rash associated with Coronavirus Disease 2019?

Mahé A, Birckel E, Krieger S, Merklen C, Bottlaender L.



J Eur Acad Dermatol Venereol. 2020 Apr 15. doi: 10.1111/jdv.16471.

Categories: Cutaneous manifestations of COVID-19

Urticarial eruption in COVID-19 infection.

Henry D, Ackerman M, Sancelme E, Finon A, Esteve E.



J Eur Acad Dermatol Venereol. 2020 Apr 15. doi: 10.1111/jdv.16472.

Categories: Cutaneous manifestations of COVID-19

Viral exanthem in COVID-19, a clinical enigma with biological significance.

Su CJ, Lee CH.



J Eur Acad Dermatol Venereol. 2020 Apr 15. doi: 10.1111/jdv.16469.

Categories: Cutaneous manifestations of COVID-19

Cutaneous manifestation of COVID-19 in images: A case report.

Avellana Moreno R, Villa E, Avellana Moreno V, Estela Villa C, Aparicio M, Fontanella A.



J Eur Acad Dermatol Venereol. 2020 Apr 24. doi: 10.1111/jdv.16531.

Categories: Cutaneous manifestations of COVID-19

Cutaneous manifestations in COVID-19: the experiences of Barcelona and Rome.

Tammaro A, Adebanjo GAR, Parisella FR, Pezzuto A, Rello J.



J Eur Acad Dermatol Venereol. 2020 Apr 24. doi: 10.1111/jdv.16530.

Categories: Cutaneous manifestations of COVID-19

Acute urticaria with pyrexia as the first manifestations of a COVID-19 infection.

van Damme C, Berlingin E, Saussez S, Accaputo O.



J Eur Acad Dermatol Venereol. 2020 Apr 24. doi: 10.1111/jdv.16523.

Categories: Cutaneous manifestations of COVID-19

Did Whatsapp® reveal a new cutaneous COVID-19 manifestation?

Duong TA, Velter C, Rybojad M, Comte C, Bagot M, Sulimovic L, Bouaziz JD.



J Eur Acad Dermatol Venereol. 2020 Apr 24. doi: 10.1111/jdv.16534.

Categories: Cutaneous manifestations of COVID-19

Acral cutaneous lesions in the time of COVID-19.

Recalcati S, Barbagallo T, Frasin LA, Prestinari F, Cogliardi A, Provero MC, Dainese E, Vanzati A, Fantini F.



J Eur Acad Dermatol Venereol. 2020 Apr 24. doi: 10.1111/jdv.16533.

Categories: Cutaneous manifestations of COVID-19

SARS-CoV-2 infection presenting as a febrile rash.

Amatore F, Macagno N, Mailhe M, Demarez B, Gaudy-Marqueste C, Grob JJ, Raoult D, Brouqui P, Richard MA.



J Eur Acad Dermatol Venereol. 2020 Apr 24. doi: 10.1111/jdv.16528.

Categories: Cutaneous manifestations of COVID-19

Chilblain-like lesions during COVID-19 epidemic: a preliminary study on 63 patients.

Piccolo V, Neri I, Filippeschi C, Oranges T, Argenziano G, Battarra VC, Berti S, Manunza F, Belloni Fortina A, Di Lernia V, Boccaletti V, De Bernardis G, Brunetti B, Mazzatenta C, Bassi A.



J Eur Acad Dermatol Venereol. 2020 Apr 24. doi: 10.1111/jdv.16526.

Categories: Cutaneous manifestations of COVID-19

Symmetric cutaneous vasculitis in COVID-19 pneumonia.

Castelnovo L, Capelli F, Tamburello A, Maria Faggioli P, Mazzone A.



J Eur Acad Dermatol Venereol. 2020 May 7. doi: 10.1111/jdv.16589.

Categories: Cutaneous manifestations of COVID-19

Vascular skin symptoms in COVID-19: a french observational study.

Bouaziz JD, Duong T, Jachiet M, Velter C, Lestang P, Cassius C, Arsouze A, Domergue Than Trong E, Bagot M, Begon E, Sulimovic L, Rybojad M.



J Eur Acad Dermatol Venereol. 2020 Apr 27. doi: 10.1111/jdv.16544.

Categories: Cutaneous manifestations of COVID-19

Histological pattern in Covid-19 induced viral rash.

Zengarini C, Orioni G, Cascavilla A, Horna Solera C, Fulgaro C, Misciali C, Patrizi A, Gaspari V.



J Eur Acad Dermatol Venereol. 2020 May 2. doi: 10.1111/jdv.16569.

Categories: Cutaneous manifestations of COVID-19

Acro-ischemia in hospitalized COVID-19 patients.

Suarez-Valle A, Fernandez-Nieto D, Diaz-Guimaraens B, Dominguez-Santas M, Carretero I, Perez-Garcia B.



J Eur Acad Dermatol Venereol. 2020 May 7. doi: 10.1111/jdv.16592.

Categories: Cutaneous manifestations of COVID-19

Pityriasis rosea as a cutaneous manifestation of COVID-19 infection.

Ehsani AH, Nasimi M, Bigdelo Z.



J Eur Acad Dermatol Venereol. 2020 May 2. doi: 10.1111/jdv.16579.

Categories: Cutaneous manifestations of COVID-19

The use of Google trends for acral symptoms during COVID-19 outbreak in France.

Kluger N, Scrivener Y.



J Eur Acad Dermatol Venereol. 2020 May 2. doi: 10.1111/jdv.16572.

Categories: Cutaneous manifestations of COVID-19

Drug-induced vasculitis in a patient with COVID-19.

Ramirez AV, Efe D, Fischer M.



J Eur Acad Dermatol Venereol. 2020 May 7. doi: 10.1111/jdv.16588.

Categories: Cutaneous manifestations of COVID-19

A late onset widespread skin rash in a previous Covid-19 infected patient: viral or multidrug effect?

Skroza N, Bernardini N, Balduzzi V, Mambrin A, Marchesiello A, Michelini S, Tolino E, Proietti I, Di Cristofano C, Petrozza V, Potenza C.



J Eur Acad Dermatol Venereol. 2020 May 18. doi: 10.1111/jdv.16633.

Categories: Cutaneous manifestations of COVID-19

Atypical erythema multiforme palmar plaques lesions due to Sars-Cov-2.

Janah H, Zinebi A, Elbenaye J.



J Eur Acad Dermatol Venereol. 2020 May 9. doi: 10.1111/jdv.16623.

Categories: Cutaneous manifestations of COVID-19

Urticarial eruption in Coronavirus Disease 2019 (COVID-19) infection: a case report in Tangerang, Indonesia.

Gunawan C, Angela, Widysanto A.



J Eur Acad Dermatol Venereol. 2020 May 9. doi: 10.1111/jdv.16622. 

Categories: Cutaneous manifestations of COVID-19

A clinicopathological study of 8 patients with COVID-19 pneumonia and a late-onset exanthema.

Herrero-Moyano M, Capusan TM, Andreu-Barasoain M, Alcántara-González J, Ruano-Del Salado M, Sánchez-Largo Uceda ME, Calzado-Villarreal L, Pérez-González Y.



J Eur Acad Dermatol Venereol. 2020 May 19. doi: 10.1111/jdv.16631.

Categories: Cutaneous manifestations of COVID-19

Acute Generalized Exanthematous Pustulosis with Erythema Multiforme-Like lesions in a COVID-19 woman.

Robustelli Test E, Vezzoli P, Carugno A, Raponi F, Gianatti A, Rongioletti F, Sena P.



J Eur Acad Dermatol Venereol. 2020 May 9. doi: 10.1111/jdv.16613. 

Categories: Cutaneous manifestations of COVID-19

Reply to "Acute urticaria with pyrexia as the first manifestations of a COVID-19 infection": Urticaria-like lesions in COVID-19 patients are not really urticaria. A case with clinicopathologic correlation.

Rodríguez-Jiménez P, Chicharro P, De Argila D, Muñoz-Hernández P, Llamas-Velasco M.



J Eur Acad Dermatol Venereol. 2020 May 9. doi: 10.1111/jdv.16618.

Categories: Cutaneous manifestations of COVID-19

Histologic features of long lasting chilblain-like lesions in a pediatric COVID-19 patient.

Locatelli AG, Robustelli Test E, Vezzoli P, Carugno A, Moggio E, Consonni L, Gianatti A, Sena P.



J Eur Acad Dermatol Venereol. 2020 May 9. doi: 10.1111/jdv.16617. 

Categories: Cutaneous manifestations of COVID-19

Chilblain acral lesions in the COVID-19 era. Are they marker of infection in asymptomatic patients?

Ramondetta A, Panzone M, Dapavo P, Ortoncelli M, Giura MT, Licciardello M, Rozzo G, Siliquini N, Fierro MT, Ribero S.



J Eur Acad Dermatol Venereol. 2020 May 18. doi: 10.1111/jdv.16636.

Categories: Cutaneous manifestations of COVID-19

Fever with Rash in COVID-19: Viral Exanthema or Secondary Lesions?

Goldust M, Abdelmaksoud A, Shuang Z, Xiang C, Navarini AA.



J Eur Acad Dermatol Venereol. 2020 May 19. doi: 10.1111/jdv.16639

Categories: Cutaneous manifestations of COVID-19

Chilblain acral lesions in the COVID -19 era. Are they marker of infection in asymptomatic patients?

Ramondetta A, Panzone M, Dapavo P, Ortoncelli M, Giura MT, Licciardello M, Rozzo G, Siliquini N, Fierro MT, Ribero S.



J Eur Acad Dermatol Venereol. 2020 May 18. doi: 10.1111/jdv.166636

Categories: Cutaneous manifestations of COVID-19

Cutaneous small vessel vasculitis secondary to COVID-19 infection: A case report

Mayor-Ibarguren A, Feito-Rodriguez M, Quintana Castanedo L, Ruiz-Bravo E, Montero Vega D, Herranz-Pinto P.



J Eur Acad Dermatol Venereol. 2020 May 22 doi: 10.1111/jdv.16670.

Categories: Cutaneous manifestations of COVID-19

A case of cefditoren‐induced Acute Generalized Exanthematous Pustulosis during COVID‐19 pandemics. Severe Cutaneous Adverse Reactions (SCARs) are an issue

I. Torres‐Navarro, C. Abril‐Pérez, J. Roca‐Ginés, J. Sánchez‐Arráez, R. Botella‐Estrada



J Eur Acad Dermatol Venereol. 2020 May 26;10.1111/jdv.16664. doi: 10.1111/jdv.16664.

Categories: Cutaneous manifestations of COVID-19

Iatrogenic dermatitis in times of COVID-19: A pandemic within a pandemic

Bhatia R, Sindhuja T, Bhatia S, Dev T, Gupta A, Bajpai M, Gupta S.



J Eur Acad Dermatol Venereol. 2020 Jun 4. doi: 10.1111/jdv.16710.

Categories: Cutaneous manifestations of COVID-19

Urticaria (angioedema) and COVID- 19 infection

Najafzadeh M, Shahzad F, Ghaderi N, Ansari K, Jacob B, Wright A.



J Eur Acad Dermatol Venereol. 2020 Jun 11. doi: 10.1111/jdv.16721. [Epub ahead of print]. Case report.

Categories: Cutaneous manifestations of COVID-19

No antibody response in acral cutaneous manifestations associated with COVID-19 ?

Mahieu R, Tillard L, Le Guillou-Guillemette H, Vinatier E, Jeannin P, Croué A, Le Corre Y, Vandamme YM.



J Eur Acad Dermatol Venereol. 2020 Jun 2. doi: 10.1111/jdv.16688.

Categories: Cutaneous manifestations of COVID-19

Acral purpuric lesions (Erythema multiforme type) associated with thrombotic vasculopathy in a child during the COVID-19 pandemic

García-Gil MF, García García M, Monte Serrano J, Prieto-Torres L, Ara-Martín M.



J Eur Acad Dermatol Venereol. 2020 May 20. doi: 10.1111/jdv.16644.

Categories: Cutaneous manifestations of COVID-19

Diversity of clinical appearance of cutaneous manifestations in the course of COVID‐19

Guarneri C, Venanzi Rullo E, Gallizzi R, Ceccarelli M, Cannavò SP, Nunnari G.



J Eur Acad Dermatol Venereol. 2020 May 22. doi: 10.1111/jdv.16669.

Categories: Cutaneous manifestations of COVID-19

Cutaneous small-vessel vasculitis associated with novel 2019 coronavirus SARS-CoV-2 infection (COVID-19)

Dominguez-Santas M, Diaz-Guimaraens B, Garcia Abellas P, Moreno-Garcia Del Real C, Burgos-Blasco P, Suarez-Valle A.



J Eur Acad Dermatol Venereol. 2020 May 26. doi: 10.1111/jdv.16663.

Categories: Cutaneous manifestations of COVID-19

Late onset of acral necrosis after SARS-CoV-2 infection resolution

Balestri R, Termine S, Rech G, Girardelli CR.



J Eur Acad Dermatol Venereol. 2020 May 26. doi: 10.1111/jdv.16668.

Categories: Cutaneous manifestations of COVID-19

COVID-19 Presenting with Atypical Sweet’s Syndrome

Taşkın B, Vural S, Altuğ E, Demirkesen C, Kocatürk E, Çelebi İ, Ferhanoğlu B, Alper S.



J Eur Acad Dermatol Venereol. 2020 May 26. doi: 10.1111/jdv.16662.

Categories: Cutaneous manifestations of COVID-19

Acro-ischemia and COVID-19 infection: clinical and histopathological features

Calvão J, Relvas M, Pinho A, Brinca A, Cardoso JC.



J Eur Acad Dermatol Venereol. 2020 Jun 2. doi: 10.1111/jdv.16687.

Categories: Cutaneous manifestations of COVID-19

COVID-19: how it can look on the skin. Clinical and pathological features in twenty COVID-19 patients observed in Bologna, northeastern Italy

Gaspari V, Neri I, Misciali C, Patrizi A.



J Eur Acad Dermatol Venereol. 2020 Jun 3. doi: 10.1111/jdv.16693.

Categories: Cutaneous manifestations of COVID-19

The red half moon nail sign: a novel manifestation of Coronavirus infection

Neri I, Guglielmo A, Virdi A, Gaspari V, Starace M, Piraccini BM.



J Eur Acad Dermatol Venereol. 2020 Jun 13. doi: 10.1111/jdv.16747.

Categories: Cutaneous manifestations of COVID-19

Erythema multiforme and Kawasaki disease associated with COVID‐19 infection in children

Labé P, Ly A, Sin C, Nasser M, Chapelon-Fromont E, Ben Saïd P, Mahé E.



J Eur Acad Dermatol Venereol. 2020 May 26. doi: 10.1111/jdv.16666.

Categories: Cutaneous manifestations of COVID-19

Exanthema and eosinophilia in Covid-19 patients: has viral infection a role in drug induced exanthemas?

Rosell-Díaz AM, Mateos-Mayo A, Nieto-Benito LM, Balaguer-Franch I, Hernández de E, la Torre-Ruiz, Laínez-Nuez A, Suárez-Fernández R, Bergón-Sendín M.



J Eur Acad Dermatol Venereol. 2020 Jun 4. doi: 10.1111/jdv.16709.

Categories: Cutaneous manifestations of COVID-19

Cutaneous involvement during COVID-19 pandemic: an emerging sign of infection

Annunziata MC, Patrì A, Ruggiero A, Di Guida A, Menicanti C, Greco V, Fabbrocini G.



J Eur Acad Dermatol Venereol. 2020 Jun 18. doi: 10.1111/jdv.16769.

Categories: Cutaneous manifestations of COVID-19

The broad spectrum of dermatological manifestations in COVID-19. Clinical and histopathological features learned from a series of 34 cases

Rubio-Muniz CA, Puerta-Peña M, Falkenhain-López D, Arroyo-Andrés J, Agud-Dios M, Rodriguez-Peralto JL, Ortiz-Romero PL, Rivera-Díaz R.



J Eur Acad Dermatol Venereol. 2020 Jun 11. doi: 10.1111/jdv.16734.

Categories: Cutaneous manifestations of COVID-19

Histology of skin lesions establishes that the vesicular rash associated with COVID-19 is not “varicella-like”

Mahé A, Birckel E, Merklen C, Lefèbvre P, Hannedouche C, Jost M, Droy-Dupré L.



J Eur Acad Dermatol Venereol. 2020 Jun 5. doi: 10.1111/jdv.16706.

Categories: Cutaneous manifestations of COVID-19

COVID-19 AND OUTBREAK OF CHILBLAINS: ARE THEY RELATED?

Lesort C, Kanitakis J, Villani A, Ducroux E, Bouschon P, Fattouh K, Bensaid B, Danset M, Jullien D.



J Eur Acad Dermatol Venereol. 2020 Jun 27. doi: 10.1111/jdv.16779.

Categories: Cutaneous manifestations of COVID-19

Eosinophilic granulomatosis with polyangiitis mimicking COVID-19: a case report

Hashizume H, Sano Y, Furukawa S, Imokawa S.



J Eur Acad Dermatol Venereol. 2020 Jun 4. doi: 10.1111/jdv.16705.

Categories: Cutaneous manifestations of COVID-19

Retiform purpura as a dermatological sign of COVID-19 coagulopathy

Bosch-Amate X, Giavedoni P, Podlipnik S, Andreu-Febrer C, Sanz-Beltran J, Garcia-Herrera A, Alós L, Mascaró JM Jr.



J Eur Acad Dermatol Venereol. 2020 Jun 3. doi: 10.1111/jdv.16689.

Categories: Cutaneous manifestations of COVID-19

COVID-19 Lockdown induced acral dermatosis in children

Bodak N, Chiaverini C, Barbarot S.



J Eur Acad Dermatol Venereol. 2020 Jun 28. doi: 10.1111/jdv.16797.

Categories: Cutaneous manifestations of COVID-19

A clinical, histopathological and laboratory study of 19 consecutive Italian paediatric patients with chilblain-like lesions: lights and shadows on the relationship with COVID-19 infection

El Hachem M, Diociaiuti A, Concato C, Carsetti R, Carnevale C, Ciofi Degli Atti M, Giovannelli L, Latella E, Porzio O, Rossi S, Stracuzzi A, Zaffina S, Onetti Muda A, Zambruno G, Alaggio R.



J Eur Acad Dermatol Venereol. 2020 May 31. doi: 10.1111/jdv.16682.

Categories: Cutaneous manifestations of COVID-19

Histological findings in chilblain-lupus like COVID lesions: in search of an answer to understand their etiology.

Rodríguez-Villa Lario A, Vega-Díez D, González-Cañete M, Gómez-Zubiaur A, Pérez-Mesonero R, Bandini M, Polo-Rodríguez I, Vélez-Velázquez D, Trasobares-Marugán L.



J Eur Acad Dermatol Venereol. 2020 Jun 12. doi: 10.1111/jdv.16733

Categories: Cutaneous manifestations of COVID-19

Major cluster of pediatric “ true ” primary chilblains during the COVID-19 pandemic:a consequence of lifestyle changes due to lockdown

Iria N, Annalucia V, Ilaria C, Alba G, Tiziana L, Liliana G, Cosimo M, Annalisa P, Marcello L.



J Eur Acad Dermatol Venereol. 2020 Jun 13. doi: 10.1111/jdv.16751.

Categories: Cutaneous manifestations of COVID-19

An unusual case of bullous hemorrhagic vasculitis in a COVID-19 patient

Negrini S, Guadagno A, Greco M, Parodi A, Burlando M.



J Eur Acad Dermatol Venereol. 2020 Jun 19. doi: 10.1111/jdv.16760.

Categories: Cutaneous manifestations of COVID-19

COVID-19 and cutaneous manifestations: A systematic review

Zhao Q, Fang X, Pang Z, Zhang B, Liu H, Zhang F.



J Eur Acad Dermatol Venereol. 2020 Jun 28. doi: 10.1111/jdv.16778

Categories: Cutaneous manifestations of COVID-19

Cutaneous manifestations of hospitalized COVID-19 patients: A report of six cases with clinicopathologic features and viral RNA in situ hybridization

Bitar C, Chan MP, Harms PW, Fullen DR, Gudjonsson JE, Eshaq M, Renati S, Nikle AB, Allen A, Hawkins SD, Huerta T, Lowe L, Andea AA.



J Eur Acad Dermatol Venereol. 2020 Jun 13. doi: 10.1111/jdv.16741.

Categories: Cutaneous manifestations of COVID-19

Papular-Purpuric Exanthem in a COVID-19 Patient: Clinical and Dermoscopic Description

Larrondo J, Cabrera R, Gosch M, Larrondo F, Aylwin M, Castro A.



J Eur Acad Dermatol Venereol. 2020 Jun 12. doi: 10.1111/jdv.16732.

Categories: Cutaneous manifestations of COVID-19

Urticarial vasculitis in COVID-19 infection: a vasculopathy-related symptom?

de Perosanz-Lobo D, Fernandez-Nieto D, Burgos-Blasco P, Selda-Enriquez G, Carretero I, Moreno C, Fernández-Guarino M.



J Eur Acad Dermatol Venereol. 2020 Jun 8. doi: 10.1111/jdv.16713.

Categories: Cutaneous manifestations of COVID-19

A generalized purpuric eruption with histopathologic features of leucocytoclastic vasculitis in a patient severely ill with COVID-19

Caputo V, Schroeder J, Rongioletti F.



J Eur Acad Dermatol Venereol. 2020 Jun 12. doi: 10.1111/jdv.16737.

Categories: Cutaneous manifestations of COVID-19

Cutaneous autoimmune diseases during COVID 19 pandemic

Günther C, Aschoff R, Beissert S



J Eur Acad Dermatol Venereol. 2020 Jun 13.doi.org/10.1111/jdv.16753

Categories: Cutaneous manifestations of COVID-19

Relapsing symmetric livedo reticularis in a patient with COVID‐19 infection

Verheyden M, Grosber M, Gutermuth J, Velkeniers B.



J Eur Acad Dermatol Venereol. 2020 Jun 25. doi: 10.1111/jdv.16773.

Categories: Cutaneous manifestations of COVID-19

Clinical and histological characterization of late appearance maculopapular eruptions in association with the coronavirus disease 2019. A case series of seven patients.

Reymundo A, Fernáldez-Bernáldez A, Reolid A, Butrón B, Fernández-Rico P, Muñoz-Hernández P, De Argila D, Llamas-Velasco M.



J Eur Acad Dermatol Venereol. 2020 Jun 4. doi: 10.1111/jdv.16707.

Categories: Cutaneous manifestations of COVID-19

Cutaneous manifestations of SARS-CoV-2 infection: a clinical update

Gisondi P, PIaserico S, Bordin C, Alaibac M, Girolomoni G, Naldi L.



J Eur Acad Dermatol Venereol. 2020 Jun 25. doi: 10.1111/jdv.16774.

Categories: Cutaneous manifestations of COVID-19

COVID-19-related acute genital ulcers

Falkenhain-López D, Agud-Dios M, Ortiz-Romero PL, Sánchez-Velázquez A.



J Eur Acad Dermatol Venereol. 2020 Jun 13. doi: 10.1111/jdv.16740.

Categories: Cutaneous manifestations of COVID-19

SARS-CoV-2, skin lesions and the need of a multidisciplinary approach

Cabrera-Hernández R, Solano-Solares E, Chica-Guzmán V, Fernández-Guarino M, Fernández-Nieto D, Ortega-Quijano D, de-Andrés-Martín A, Moreno C, Carretero-Barrio I, García-Abellás P, González-de-Olano D, de-la-Hoz-Caballer B.



J Eur Acad Dermatol Venereol. 2020 Jun 13. doi: 10.1111/jdv.16745.

Categories: Cutaneous manifestations of COVID-19

Introductory histopathologic findings may shed light on COVID19 pediatric hyperinflammatory shock syndrome

Schnapp A, Abulhija H, Maly A, Armoni-Weiss G, Levin Y, Faitatziadou SM, Molho-Pessach V.



J Eur Acad Dermatol Venereol. 2020 Jun 13. doi: 10.1111/jdv.16749.

Categories: Cutaneous manifestations of COVID-19

Catastrophic acute bilateral lower limbs necrosis associated with COVID-19 as a likely consequence of both vasculitis and coagulopathy

Del Giudice P, Boudoumi D, Le Guen B, Reverte M, Gutnecht J, Lacour JP, Kraemer JP, Motard A, Roa M.



J Eur Acad Dermatol Venereol. 2020 Jun 18. doi: 10.1111/jdv.16763.

Categories: Cutaneous manifestations of COVID-19

Two cases of cutaneous eruptions due to COVID-19 infection in Singapore: New insights into the spectrum of clinical presentation and histopathology

Ho BWY, Wang D, Tan LYC, Bundele MM, Tan CH, Lim JH.



J Eur Acad Dermatol Venereol. 2020 Jun 12. doi: 10.1111/jdv.16736.

Categories: Cutaneous manifestations of COVID-19

Concurrent chilblains and retinal vasculitis in a child with COVID-19

Quintana-Castanedo L, Feito-Rodríguez M, Fernández-Alcalde C, Granados-Fernández M, Montero-Vega D, Mayor-Ibarguren A, de Lucas-Laguna R.



J Eur Acad Dermatol Venereol. 2020 Jul 2. doi: 10.1111/jdv.16801.

Categories: Cutaneous manifestations of COVID-19

Acute acral cutaneous manifestations during the COVID-19 pandemic: a single center experience.

García-Legaz Martínez M, Martínez-Doménech Á, Magdaleno-Tapial J, Valenzuela-Oñate C, Partarrieu-Mejías F, Lorca-Spröhnle J, Casanova-Esquembre A, Pérez-Ferriols A, Alegre-de Miquel V.



J Eur Acad Dermatol Venereol. 2020 Jun 26. doi: 10.1111/jdv.16777.

Categories: Cutaneous manifestations of COVID-19

Recent outbreak of chilblain-like lesions is not directly related with SARS-CoV-2 infection

Rouanet J, Lang E, Beltzung F, Evrard B, Henquell C, Joulie I, D'Incan M.



J Eur Acad Dermatol Venereol. 2020 Jun 26. doi: 10.1111/jdv.16776.

Categories: Cutaneous manifestations of COVID-19

Dermoscopy features of COVID-19-related chilblains in children and adolescents

Navarro L, Andina D, Noguera-Morel L, Hernández-Martín A, Colmenero I, Torrelo A.



J Eur Acad Dermatol Venereol. 2020 Jul 2. doi: 10.1111/jdv.16800.

Categories: Cutaneous manifestations of COVID-19

Cutaneous manifestations in SARS-CoV-2 infection (COVID-19): a French experience and a systematic review of the literature

Matar S, Oulès B, Sohier P, Chosidow O, Beylot-Barry M, Dupin N, Aractingi S.



J Eur Acad Dermatol Venereol. 2020 Jun 26. doi: 10.1111/jdv.16775.

Categories: Cutaneous manifestations of COVID-19

COVID-19-related cutaneous manifestations associated with multiple drug sensitization

Hayakawa J, Takakura H, Mizukawa Y, Shiohara T.



J Eur Acad Dermatol Venereol. 2020 Aug 18. doi: 10.1111/jdv.16878.

Categories: Cutaneous manifestations of COVID-19

Acral skin eruption observed during SARS-CoV-2 pandemic: red palms and soles.

Neri I, Patrizi A, Gabrielli L, Virdi A, Veronesi G, Corsini I, Lazzarotto T, Lanari M, Misciali C, Guglielmo A.



J Eur Acad Dermatol Venereol. 2020 Aug 20. doi: 10.1111/jdv.16881.

Categories: Cutaneous manifestations of COVID-19

Generalized Pustular Figurate Erythema. First Report in Two COVID-19 Patients on Hydroxychloroquine

Abadías-Granado I, Palma-Ruiz AM, Cerro PA, Morales-Callaghan AM, Gómez-Mateo MC, Gilaberte Y, Schwartz RA.



J Eur Acad Dermatol Venereol. 2020 Sep 1. doi: 10.1111/jdv.16903.

Categories: Cutaneous manifestations of COVID-19

Skin manifestations in COVID-19 provide a clue for disease’s pathophysiology understanding

Kubanov AA, Deryabin DG.



J Eur Acad Dermatol Venereol. 2020 Sep 1. doi: 10.1111/jdv.16902.

Categories: Cutaneous manifestations of COVID-19

A potential new trigger for aquagenic wrinkling of the palms caused by COVID-19 outbreak

Tai Y, Fukumoto T, Oka M, Nishigori C.



J Eur Acad Dermatol Venereol. 2020 Aug 31. doi: 10.1111/jdv.16906.

Categories: Cutaneous manifestations of COVID-19

Chilblains and COVID-19: further evidence against a causal association

M. Baeck, C. Peeters, A. Herman



J Eur Acad Dermatol Venereol. 2020 Aug 31. doi.org/10.1111/jdv.16901

Categories: Cutaneous manifestations of COVID-19

Cutaneous Symptoms of Patients Diagnosed with Covid-19 in One Province: A Cross-Sectional Survey

Öksüm Solak E, Baran Ketencioglu B, Aslaner H, Çinar SL, Kartal D, Benli AR, Borlu M.



J Eur Acad Dermatol Venereol. 2020 Aug 31. doi: 10.1111/jdv.16904.

Categories: Cutaneous manifestations of COVID-19

Self-reported cutaneous manifestations in 1,429 Brazilian COVID-19 patients

Miot HA, Ianhez M, Ramos PM.



J Eur Acad Dermatol Venereol. 2020 Nov 2. doi: 10.1111/jdv.17024.

Categories: Cutaneous manifestations of COVID-19

Why are chilblains underreported in Nordic countries during the COVID-19 pandemic? An analysis of Google trends

Kluger N.



J Eur Acad Dermatol Venereol. 2020 Oct 3 doi.org/10.1111/jdv.16974

Categories: Cutaneous manifestations of COVID-19

SARS-CoV-2-induced telogen effluvium: a multicentric study

O.M. Moreno‐Arrones A. Lobato‐Berezo A. Gomez‐Zubiaur S. Arias‐Santiago D. Saceda‐Corralo C. Bernardez‐Guerra R. Grimalt P. Fernandez‐Crehuet J. Ferrando R. Gil A. Hermosa‐Gelbard R. Rodrigues‐Barata D. Fernandez‐Nieto S. Merlos‐Navarro S. Vañó‐Galván



J Eur Acad Dermatol Venereol. 2020 Nov 21 doi.org/10.1111/jdv.17045

Categories: Cutaneous manifestations of COVID-19

Lack of skin manifestations in COVID-19 hospitalized patients during the second epidemic wave in Spain: a possible association with a novel SARS-CoV-2 variant. A cross-sectional study

D. Fernandez‐Nieto D. Ortega‐Quijano A. Suarez‐Valle J. Jimenez‐Cauhe P. Jaen‐Olasolo M. Fernandez‐Guarino



J Eur Acad Dermatol Venereol. 2020 Dec 1 doi.org/10.1111/jdv.17051

Categories: Cutaneous manifestations of COVID-19

Palmoplantar erythrodysesthesia: a diagnostic sign of COVID‐19

A. Nuno‐Gonzalez K. Magaletsky M. Feito Rodríguez A. Mayor Ibarguren M.J. Beato E. Ruiz Bravo P. Herranz Pinto



J Eur Acad Dermatol Venereol. 2020 Dec 8 doi.org/10.1111/jdv.17074

Categories: Cutaneous manifestations of COVID-19

Pityriasis rosea as a leading manifestation of COVID-19 infection

R. Merhy A.S. Sarkis F. Stephan



J Eur Acad Dermatol Venereol. 2020 Nov 30 doi.org/10.1111/jdv.17052

Categories: Cutaneous manifestations of COVID-19

Absence of SARS-CoV-2 RNA detection in tissue samples of COVID-19-related cutaneous lesions analyzed by real-time RT-PCR

M. F. García‐Gil J. Monte‐Serrano M. García García L. Prieto‐Torres A. J. Pascual‐del‐Riquelme I. Casas Flecha M. Ara‐Martín



J Eur Acad Dermatol Venereol. 2021 Feb 4 doi.org/10.1111/jdv.17146

Categories: Cutaneous manifestations of COVID-19

Chilblain-like lesions and COVID-19: second wave, second outbreak

V. Piccolo A. Bassi T. Russo C. Mazzatenta M. Baraldi G. Argenziano I. Neri M. Cutrone



J Eur Acad Dermatol Venereol. 2021 Feb 5 doi.org/10.1111/jdv.17145

Categories: Cutaneous manifestations of COVID-19

Relapse of chilblain-like lesions during the second wave of COVID-19

S. Recalcati T. Barbagallo S. Tonolo M. Milani F. Fantini



J Eur Acad Dermatol Venereol. 2021 Feb 15 doi.org/10.1111/jdv.17168

Categories: Cutaneous manifestations of COVID-19

Chilblains in a child with confirmed SARS-CoV-2 infection: a red flag for late onset skin manifestation in previously infected individuals

I. Neri F. Conti A. Virdi A. Guglielmo L. Leonardi I. Corsini C. Ghizzi L. Gabrielli T. Lazzarotto M. Lanari A. Patrizi C. Misciali



J Eur Acad Dermatol Venereol. 2021 Mar 2 doi.org/10.1111/jdv.17194

Categories: Cutaneous manifestations of COVID-19

Association Between COVID-19 and Chilblains: A Case-Control Study

D. Ortega‐Quijano D. Fernandez‐Nieto J. Jimenez‐Cauhe J.L. Cortes‐Cuevas D. Marcos‐Mencia M. Rodriguez‐Dominguez G. Segurado‐Miravalles M. Fernandez‐Guarino P. Jaen‐Olasolo



J Eur Acad Dermatol Venereol. 2021 Mar 2 doi.org/10.1111/jdv.17195

Categories: Cutaneous manifestations of COVID-19

Follow-up of dermatological manifestations in non-critical hospitalized patients with COVID-19 pneumonia and their prognostic correlation with disease severity

A. García‐Irigoyen G.A. Acatitla‐Acevedo A. Barrera‐Godínez S. Méndez‐Flores J. Domínguez‐Cherit



J Eur Acad Dermatol Venereol. 2021 Mar 17 doi.org/10.1111/jdv.17236

Categories: Cutaneous manifestations of COVID-19

Periocular capillaritis in a COVID-19 positive patient: report of a case

A. Paganelli F. Garbarino L. Bigi



J Eur Acad Dermatol Venereol. 2021 Mar 16 doi.org/10.1111/jdv.17227

Categories: Cutaneous manifestations of COVID-19

Under-representation of people of African ancestry in publications on the cutaneous manifestations of COVID-19: coincidence or physiology?

C Cassius L Frumholtz A de Masson O Dadzie A Petit Saint‐Louis CORE (COvid Research) group



J Eur Acad Dermatol Venereol. 2021 Apr 18 doi.org/10.1111/jdv.17289

Categories: Cutaneous manifestations of COVID-19

Recurrence of previous chilblain lesions during the second wave of COVID-19: can we still doubt the correlation with SARS-CoV-2?

S Signa AR Sementa MC Coccia C Pastorino G Viglizzo S Viola S Volpi C Occella D Bleidl M Acquila E Castagnola A Ravelli F Manunza



J Eur Acad Dermatol Venereol. 2021 Apr 19 doi.org/10.1111/jdv.17283

Categories: Cutaneous manifestations of COVID-19

Covid-19-triggered sarcoidal granulomas mimicking scar sarcoidosis

A Polat Ekinci N Büyükbabani S Meşe G Pehlivan NG Okumuş A Ağaçfidan E Özkaya



J Eur Acad Dermatol Venereol. 2021 Apr 19 doi.org/10.1111/jdv.17286

Categories: Cutaneous manifestations of COVID-19

Acute postinfectious Pityriasis Rubra Pilaris as a cutaneous manifestation in COVID-19: a case report and its dermoscopic features

D. Kadylak, W. Barańska-Rybak



J Eur Acad Dermatol Venereol. 2021 May 31 oi/full/10.1111/jdv.17424

Categories: Cutaneous manifestations of COVID-19

Non-acral skin manifestations during the COVID-19 epidemic: COVIDSKIN study by the French Society of Dermatology

R. Guelimi, R. Salle, L. Dousset, H. Assier, S. Fourati, Z. Bhujoo, S. Barbarot, C. Boulard, C. Cazanave, A. Colin, E. Kostrzewa, C. Lesort, A. Levy Roy, F. Lombart, J. Marco Bonnet, L. Marty, J.B. Monfort, L. Riffaud, M. Samimi, M. Tardieu, E. Sbidian, P. Wolkenstein, L. Le Cleach, M. Beylot-Barry



J Eur Acad Dermatol Venereol. 2021 Apr 29 com/doi/10.1111/jdv.17322

Categories: Cutaneous manifestations of COVID-19

Heterogeneous red-white discoloration of the nail bed and distal onycholysis in a patient with COVID-19

Betul Demir, Esma Inan Yuksel, Demet Cicek, Sedatcan Turkoglu



J Eur Acad Dermatol Venereol. 2021 May 13 doi/abs/10.1111/jdv.17347

Categories: Cutaneous manifestations of COVID-19

Recurrent injection-site reactions after incorrect subcutaneous administration of the BNT162b2 vaccine against SARS-CoV-2

M. Gyldenløve, L. Skov, C.B. Hansen, P. Garred



J Eur Acad Dermatol Venereol. 2021 May 12 oi/full/10.1111/jdv.17341

Categories: Cutaneous manifestations of COVID-19

Frequency of relapse and persistent cutaneous symptoms after a first episode of chilblain-like lesion during the COVID-19 pandemic

Parna Moghadam, Laure Frumholtz, Léa Jaume, Adèle De Masson, Marie Jachiet, Edouard Begon, Luc Sulimovic, Antoine Petit, Hervé Bachelez, Martine Bagot, Jean-David Bouaziz, Charles Cassius, Saint-Louis CORE (COvid REsearch)



J Eur Acad Dermatol Venereol. 2021 May 25 com/doi/10.1111/jdv.17393

Categories: Cutaneous manifestations of COVID-19

Urticarial Vasculitis revealing immunolabelled nucleocapsid protein of SARS-CoV-2 in two Brazilian asymptomatic patients: the tip of the COVID-19 hidden iceberg?

Paulo Ricardo Criado, Roberta Fachini Jardim Criado, Raffaele Gianotti, Beatrice Artinez Zugaib Abdalla, Thais Prota Hussein Pincelli, Alexandre Osores Michalany, Nilceo Schwery Michalany



J Eur Acad Dermatol Venereol. 2021 May 25 com/doi/10.1111/jdv.17391

Categories: Cutaneous manifestations of COVID-19

Development of eruptive pseudoangiomatosis following COVID-19 immunization – Apropos of 5 cases

A. Mohta, S. K. Jain, R. D. Mehta, A. Arora



J Eur Acad Dermatol Venereol. 2021 Jul 8 com/doi/10.1111/jdv.17499

Categories: Cutaneous manifestations of COVID-19

Cutaneous manifestations of patients hospitalized with coronavirus disease 2019 (COVID-19)

P Ramezani Darmian, Z Memarzadeh, R Aryan, Y Nahidi, Z Mehri, A taghipour, N Samimi, M Amini, P Layegh



J Eur Acad Dermatol Venereol. 2021 Jul 26 com/doi/10.1111/jdv.17557

Categories: Cutaneous manifestations of COVID-19

Retiform purpura and extensive skin necrosis as the single manifestation of SARS-CoV-2 infection

M. Brito Caldeira, M. Pestana, A.L. João, C. Fernandes, A. João, N. Cunha



J Eur Acad Dermatol Venereol. 2021 Jul 26 com/doi/10.1111/jdv.17562

Categories: Cutaneous manifestations of COVID-19

Are the chilblain-like lesions observed during the COVID-19 pandemic due to SARS-CoV-2? Systematic review and meta-analysis

V. Sánchez-García,R. Hernández-Quiles,E. de-Miguel-Balsa,A. Docampo-Simón,I. Belinchón-Romero,J.M. Ramos-Rincón



J Eur Acad Dermatol Venereol. 2021 Sep 21 com/doi/10.1111/jdv.17672

Categories: Cutaneous manifestations of COVID-19

SARS-CoV-2 in the sweat of COVID-19-positive patients: a possible route of transmission?

S. Recalcati,S. Tonolo,E. Meroni,F. Fantini



J Eur Acad Dermatol Venereol. 2021 Aug 20 oi/full/10.1111/jdv.17607

Categories: Cutaneous manifestations of COVID-19

Erythema annulare centrifugum triggered by SARS-CoV-2 infection

N. Setó-Torrent,A. Altemir,M. Iglesias-Sancho,M.T. Fernández-Figueras



J Eur Acad Dermatol Venereol. 2021 Sep 6 com/doi/10.1111/jdv.17645

Categories: Cutaneous manifestations of COVID-19

Non-invasive instrumental examinations of cutaneous, adnexal and mucosal manifestations after SARS-COV-2 infection in adult and children

I. Proietti,E. Tolino,A. Mambrin,N. Skroza,N. Bernardini,A. Marchesiello,F. Marraffa,S. Michelini,G. Rossi,S. Volpe,E. Del Giudice,R. Lubrano,C. Potenza



J Eur Acad Dermatol Venereol. 2021 Nov 9 doi.org/10.1111/jdv.17805

Categories: Cutaneous manifestations of COVID-19

Is there a POST-COVID dermatological syndrome? The integrated dermato-infectious disease experience of a single center

F. Diotallevi,S. Mazzanti,P. Properzi,S. Olivieri,A. Giacometti,A. Offidani



J Eur Acad Dermatol Venereol. 2021 Nov 9 doi.org/10.1111/jdv.17803

Categories: Cutaneous manifestations of COVID-19

COVID-19 cutaneous manifestations in pediatric patients: 24 MIS-C and 6 Kawasaki disease cases

A. Tammaro,D. Karim,G.A.R. Adebanjo,F.R. Parisella,C. Chello,A.F. Salih,J. Rello



J Eur Acad Dermatol Venereol. 2021 Nov 22 doi.org/10.1111/jdv.17828

Categories: Cutaneous manifestations of COVID-19

Pityrosporum folliculitis in critically ill COVID-19 patients

F.L.X. Peres,R.R. Bonamigo,G.B. Bottega,F.L. Staub,A.S. Cartell,R.M. Bakos



J Eur Acad Dermatol Venereol. 2021 Nov 27 doi.org/10.1111/jdv.17842

Categories: Cutaneous manifestations of COVID-19

Multisystem inflammatory syndrome in adults (MIS-A): a new addition to Covid-19 puzzle

K. Hajra,U. Chakraborty,K. Chatterjee,A. Chandra,S. Halder



J Eur Acad Dermatol Venereol. 2021 Nov 27 doi.org/10.1111/jdv.17841

Categories: Cutaneous manifestations of COVID-19

Eruptive pyogenic granulomas following COVID-19.

C.A. Maronese,C. Moltrasio,D.A. Marletta,G. Genovese,A.V. Marzano



J Eur Acad Dermatol Venereol. 2022 Jan 24 doi.org/10.1111/jdv.17953

Categories: Cutaneous manifestations of COVID-19

Covid-19 and Covid-19 vaccine can slide along sides: a report of two cases of unilateral periflexural exanthema

A. Sechi,A. Bassi,C. Mazzatenta,M. Cutrone,L. Naldi,G. Argenziano,V. Piccolo



J Eur Acad Dermatol Venereol. 2022 Mar 19 doi.org/10.1111/jdv.18093

Categories: Cutaneous manifestations of COVID-19

Autoimmune bullous dermatoses associated with COVID-19 outbreak in Russian patients: a single case series

A. Lepekhova,E. Grekova,O. Olisova,E. Dunaeva,S. Ali,I. Maximov,N. Teplyuk



J Eur Acad Dermatol Venereol. 2022 Mar 30 doi.org/10.1111/jdv.18118

Categories: Cutaneous manifestations of COVID-19

A rare case of reactive granulomatous dermatitis during COVID-19: a possible role of cephalosporine and potential mechanisms

A. Aoki,M. Yamane,Y. Aoyama



J Eur Acad Dermatol Venereol. 2022 Mar 30 doi.org/10.1111/jdv.18119

Categories: Cutaneous manifestations of COVID-19

Lessons from India's COVID-19 crisis: Meyerozyma guillermondii presenting in a mucormycosis-like picture

M. Shanshal



J Eur Acad Dermatol Venereol. 2022 Apr 18 doi.org/10.1111/jdv.18159

Categories: Biologics and immunomodulatory therapies

Should SARS-CoV-2 influence immunosuppressive therapy for autoimmune blistering diseases?

Di Altobrando A, Patrizi A, Bardazzi F.



J Eur Acad Dermatol Venereol. 2020 Apr 17. doi: 10.1111/jdv.16491.

Categories: Biologics and immunomodulatory therapies

SARS-CoV-2 infection in a psoriatic patient treated with IL-23 inhibitor.

Messina F, Piaserico S.



J Eur Acad Dermatol Venereol. 2020 Apr 15. doi: 10.1111/jdv.16468.

Categories: Biologics and immunomodulatory therapies

Safety of dupilumab in severe atopic dermatitis and infection of Covid-19: two case reports.

Ferrucci S, Romagnuolo M, Angileri L, Berti E, Tavecchio S.



J Eur Acad Dermatol Venereol. 2020 Apr 24. doi: 10.1111/jdv.16527.

Categories: Biologics and immunomodulatory therapies

No evidence of increased risk for COVID-19 infection in patients treated with Dupilumab for atopic dermatitis in a high-epidemic area - Bergamo, Lombardy, Italy.

Carugno A, Raponi F, Locatelli AG, Vezzoli P, Gambini DM, Di Mercurio M, Robustelli Test E, Sena P.



J Eur Acad Dermatol Venereol. 2020 Apr 27. doi: 10.1111/jdv.16552.

Categories: Biologics and immunomodulatory therapies

"Toxic Erythema" and Eosinophilia Associated to Tocilizumab Therapy in a COVID-19 Patient

Sernicola A, Carnicelli G, Di Fraia M, Chello C, Furlan C, Muharremi R, Paolino G, Grieco T.



J Eur Acad Dermatol Venereol. 2020 May 9. doi: 10.1111/jdv.16620.

Categories: Biologics and immunomodulatory therapies

Evolution of COVID-19 infection in 4 psoriatic patients treated with biological drugs.

Conti A, Lasagni C, Bigi L, Pellacani G.



J Eur Acad Dermatol Venereol. 2020 May 7. doi: 10.1111/jdv.16587.

Categories: Biologics and immunomodulatory therapies

Improvement of SARS-CoV2 symptoms following guselkumab injection in a psoriatic patient.

Benhadou F, Del Marmol V.



J Eur Acad Dermatol Venereol. 2020 May 7. doi: 10.1111/jdv.16590. 

Categories: Biologics and immunomodulatory therapies

SARS-CoV-2 asymptomatic infection in a patient under treatment with dupilumab.

Caroppo F, Biolo G, Belloni Fortina A.



J Eur Acad Dermatol Venereol. 2020 May 9. doi: 10.1111/jdv.16619.

Categories: Biologics and immunomodulatory therapies

SARS-CoV-2 infection in a psoriatic patient treated with IL-17 inhibitor.

Balestri R, Rech G, Girardelli CR.



J Eur Acad Dermatol Venereol. 2020 May 2. doi: 10.1111/jdv.16571.

Categories: Biologics and immunomodulatory therapies

Prior treatment with immunosuppressants among COVID-19 inpatients in one hospital in Spain

Pastor-Nieto MA, Checa-Díaz P, González-Muñoz P, Martín-Fuentes A, Vergara-Sánchez A, Sánchez-Herreros C, Jiménez-Blázquez E, Cabana-Navia R, Martínez-Mariscal J, Cobo-Rodríguez P, Checa-Recio I, Gatica-Ortega ME, Torralba M, De Eusebio-Murillo E.



J Eur Acad Dermatol Venereol. 2020 Jun 28. doi.org/10.1111/jdv.16798

Categories: Biologics and immunomodulatory therapies

Systemic or biologic treatment in psoriasis patients does not increase the risk of a severe form of COVID-19

Fougerousse AC, Perrussel M, Bécherel PA, Begon E, Pallure V, Zaraa I, Chaby G, Parier J, Kemula M, Mery-Bossard L, Poreaux C, Taieb C, Maccari F, Reguiai Z; GEM Resopso.



J Eur Acad Dermatol Venereol. 2020 Jun 21. doi: 10.1111/jdv.16761.

Categories: Biologics and immunomodulatory therapies

Compliance, safety concerns and anxiety in patients treated with biologics for psoriasis during the COVID-19 pandemic national lockdown: A multicenter study in the Czech Republic

Rob F, Hugo J, Tivadar S, Boháč P, Gkalpakiotis S, Vargová N, Arenbergerová M, Hercogová J.



J Eur Acad Dermatol Venereol. 2020 Jun 27. doi: 10.1111/jdv.16771. [

Categories: Biologics and immunomodulatory therapies

Toxic epidermal necrolysis and co-existent SARS-CoV-2 (COVID-19) treated with Intravenous Immunoglobulin: "Killing 2 birds with one stone ”

Saha M, D'Cruz A, Paul N, Healy R, Collins D, Charles DA, Sahu S, Fonia A.



J Eur Acad Dermatol Venereol. 2020 Aug 17. doi: 10.1111/jdv.16887.

Categories: Biologics and immunomodulatory therapies

Position Statement for a Pragmatic Approach to Immunotherapeutics in Patients with Inflammatory Skin Diseases during the COVID-19 Pandemic and Beyond

J. Beecker K.A. Papp J. Dutz R.B. Vender R. Gniadecki C. Cooper P. Gisondi M. Gooderham C.H. Hong M.G. Kirchhof C.W. Lynde C. Maari Y. Poulin L. Puig



J Eur Acad Dermatol Venereol. 2021 Feb 3 doi.org/10.1111/jdv.17075

Categories: Biologics and immunomodulatory therapies

Understanding Views of Patients on Biologics for Psoriasis Amid the COVID-19 Pandemic

K. Pandher C.L. Porter H.S. Patel W.W. Huang S.R. Feldman



J Eur Acad Dermatol Venereol. 2020 Nov 17 doi.org/10.1111/jdv.17091

Categories: Biologics and immunomodulatory therapies

Good tolerance of hyaluronic acid injections during the Covid-19 pandemic period: a prospective observational real-life study of a cohort of 1093 patients with a 3 month-follow up period

Michael Naouri Serge Dahan Anne Le Pillouer Prost Phrynée Coutant‐Foulc Catherine Raimbault Françoise Cucurella Laurence Beille Muriel Creusot Martine Baspeyras Martine Darchy Randa Khallouf Hugues Cartier Isabelle Baratte Magali Dubois Olivier Cogrel Hans Laubach Groupe de Dermatologie Esthétique et Correctrice de la Société Française de Dermatologie (GDEC)



J Eur Acad Dermatol Venereol. 2021 Apr 8 doi.org/10.1111/jdv.17271

Categories: Biologics and immunomodulatory therapies

Autoantibodies in Covid19 – A model for viral induced autoimmunity

J. Berger, S. Volc



J Eur Acad Dermatol Venereol. 2021 May 25 com/doi/10.1111/jdv.17396

Categories: Biologics and immunomodulatory therapies

SARS-CoV-2 Serology In Patients On Biological Therapy or Apremilast For Psoriasis: A Study of 93 Patients in the Italian Red Zone

Syed M. A. Ahmed,Martina Volontè,Eugenio Isoletta,Camilla Vassallo,Carlo Francesco Tomasini,Daniele Lilleri,Paola Zelini,Valeria Musella,Catherine Klersy,Valeria Brazzelli



J Eur Acad Dermatol Venereol. 2021 Oct 4 doi.org/10.1111/jdv.17721

Categories: Clinical set-up and service delivery

What dermatologists could do to cope with the novel coronavirus (SARS-CoV-2): a dermatologist's perspective from China.

Zhang H, Tang K, Fang R, Sun Q.



J Eur Acad Dermatol Venereol. 2020 Mar 27. doi: 10.1111/jdv.16389.

Categories: Clinical set-up and service delivery

Global coronavirus pandemic (2019-nCOV): Implication for an Italian medium size dermatological clinic of a ii level hospital.

Radi G, Diotallevi F, Campanati A, Offidani A.



J Eur Acad Dermatol Venereol. 2020 Mar 22. doi: 10.1111/jdv.16386.

Categories: Clinical set-up and service delivery

Art of performing dermoscopy during the times of coronavirus disease (COVID-19): Simple change in approach can save the day!

Jakhar D, Kaur I, Kaul S.



J Eur Acad Dermatol Venereol. 2020 Mar 29. doi: 10.1111/jdv.16412.

Categories: Clinical set-up and service delivery

Face the COVID-19 emergency: measures applied in an Italian dermatologic clinic.

Marasca C, Ruggiero A, Annunziata MC, Fabbrocini G, Megna M.



J Eur Acad Dermatol Venereol. 2020 Apr 15. doi: 10.1111/jdv.16476.

Categories: Clinical set-up and service delivery

Dermatologists and SARS-CoV-2: The impact of the pandemic on daily practice.

Gisondi P, Piaserico S, Conti A, Naldi L.



J Eur Acad Dermatol Venereol. 2020 Apr 22. doi: 10.1111/jdv.16515.

Categories: Clinical set-up and service delivery

Changes in emergency service access after spread of COVID19 across Italy

Tartari F, Guglielmo A, Fuligni F, Pileri A.



J Eur Acad Dermatol Venereol. 2020 Apr 27. doi: 10.1111/jdv.16553.

Categories: Clinical set-up and service delivery

COVID-19 and dermatology: A comprehensive guide for dermatologists.

Fahmy DH, El-Amawy HS, El-Samongy MA, Foud AA, Soliman SH, El-Kady A, Farnetani F, Conti A, Zoeir A, Eissa A, Eissa R, Puliatti S, Sighinolfi MC, Rocco B, Pellacani G.



J Eur Acad Dermatol Venereol. 2020 May 19. doi: 10.1111/jdv.16545. 

Categories: Clinical set-up and service delivery

Active implications for dermatologists in "SARS-CoV-2 era": Personal experience and review of literature.

Campanati A, Brisigotti V, Diotallevi F, D'Agostino GM, Paolinelli M, Radi G, Rizzetto G, Sapigni C, Tagliati C, Offidani A.



J Eur Acad Dermatol Venereol. 2020 May 19. doi: 10.1111/jdv.16646.

Categories: Clinical set-up and service delivery

Teledermatology for COVID-19 cutaneous lesions: substitute or supplement?

Skayem C, Cassius C, Ben Kahla M, Fiani C, Frumholtz L, Mrad M, Petit A, Zuelgaray E, Bagot M, Bouaziz JD, Duong TA.



J Eur Acad Dermatol Venereol. 2020 May 18. doi: 10.1111/jdv.16630.

Categories: Clinical set-up and service delivery

The COVID-19 outbreak in dermatologic surgery: resetting clinical priorities

E. Rossi, M. Trakatelli, L. Giacomelli, B. Ferrari, M. Francomano, G. Pellacani, C. Magnoni



J Eur Acad Dermatol Venereol. 2020 May 26 doi.org/10.1111/jdv.16672

Categories: Clinical set-up and service delivery

Teledermatology for acne during COVID-19: high patients’ satisfaction nevertheless the emergency

Ruggiero A, Megna M, Annunziata MC, Abategiovanni L, Scalvenzi M, Tajani A, Fabbrocini G, Villani A.



J Eur Acad Dermatol Venereol. 2020 Jun 13. doi: 10.1111/jdv.16746.

Categories: Clinical set-up and service delivery

A SURVEY ON TELEDERMATOLOGY (TD) USE AND DOCTORS’ PERCEPTION IN TIMES OF COVID-19

Moscarella E, Pasquali P, Cinotti E, Tognetti L, Argenziano G, Rubegni P.



J Eur Acad Dermatol Venereol. 2020 Aug 3. doi: 10.1111/jdv.16843.

Categories: Clinical set-up and service delivery

Management of biological therapies for chronic plaque psoriasis during COVID-19 emergency in Italy

Talamonti M, Galluzzo M, Chiricozzi A, Quaglino P, Fabbrocini G, Gisondi P, Marzano AV, Potenza C, Conti A, Parodi A, Belloni Fortina A, Bardazzi F, Argenziano G, Rongioletti F, Stingeni L, Micali G, Loconsole F, Venturini M, Bongiorno MR, Feliciani C, Rubegni P, Amerio P, Fargnoli MC, Pigatto P, Savoia P, Nisticò SP, Giustini S, Carugno A, Cannavò SP, Rech G, Prignano F, Offidani A, Lombardo M, Zalaudek I, Bianchi L, Peris K; PSO-BIO-COVID study group.



J Eur Acad Dermatol Venereol. 2020 Jul 31. doi: 10.1111/jdv.16841.

Categories: Clinical set-up and service delivery

RECOMMENDATIONS FOR SKIN CANCER CONSULTATION AND SURGERY DURING COVID-19 PANDEMIC

Brochez, L., Baurain, J.F., Del Marmol, V., Nikkels, A., Kruse, V., Sales, F., Stas, M., Van Laethem, A, Garmyn, M.



J Eur Acad Dermatol Venereol. 2020 Aug 12. doi: 10.1111/jdv.16772.

Categories: Clinical set-up and service delivery

Comment on “Drug reaction with eosinophilia and systemic symptoms syndrome in a patient with COVID-19”: Involvement of herpesvirus reactivations and adverse drug reactions in diverse cutaneous manifestations and overall disease severity of COVID-19

Shiohara T, Mizukawa Y



J Eur Acad Dermatol Venereol. 2020 Sep 24. doi: 10.1111/jdv.16959.

Categories: Clinical set-up and service delivery

Impact of the COVID-19 Pandemic on Inpatient Dermatology: A Multicenter Study from Hubei, China

Y. Zhang J. Wen M. Alamgir J. Xie H. Jing M. Fang J. Wang M. Zhang Z. Meng L. Yang J. Tao



J Eur Acad Dermatol Venereol. 2020 Nov 21 doi.org/10.1111/jdv.17041

Categories: Clinical set-up and service delivery

An Irish Department of Genito-Urinary Medicine in the COVID-19 Era

D. Moriarty C. O'Connor J. Bourke M. Murphy M. Horgan S. Cremin



J Eur Acad Dermatol Venereol. 2021 Feb 15 doi.org/10.1111/jdv.17169

Categories: Coronavirus drugs

Prompt onset of erythema multiforme following the first BNT162b2 SARS-CoV-2 vaccination

T. Gambichler L. Scholl L. Ocker R. Stranzenbach



J Eur Acad Dermatol Venereol. 2021 Mar 16 doi.org/10.1111/jdv.17225

Categories: Coronavirus drugs

Lichen planus arising after COVID-19 vaccination

I. Hiltun J. Sarriugarte I. Martínez‐de‐Espronceda A. Garcés C. Llanos R. Vives J.I. Yanguas



J Eur Acad Dermatol Venereol. 2021 Mar 16 doi.org/10.1111/jdv.17221

Categories: Coronavirus drugs

Persistent maculopapular rash after the first dose of Pfizer-BioNTech COVID-19 vaccine

M. Ackerman D. Henry A. Finon R. Binois E. Esteve



J Eur Acad Dermatol Venereol. 2021 Mar 30 doi.org/10.1111/jdv.17248

Categories: Coronavirus drugs

Skin manifestations of the BNT162b2 mRNA COVID-19 vaccine in healthcare workers. “COVID-arm”: a clinical and histological characterization

D. Fernandez‐Nieto J. Hammerle M. Fernandez‐Escribano CM Moreno‐del Real P. Garcia‐Abellas I. Carretero‐Barrio E. Solano‐Solares B de‐la‐Hoz‐Caballer J. Jimenez‐Cauhe D. Ortega‐Quijano M. Fernandez‐Guarino



J Eur Acad Dermatol Venereol. 2021 Mar 30 doi.org/10.1111/jdv.17250

Categories: Coronavirus drugs

Pityriasis rosea following CoronaVac COVID-19 vaccination: a case report

E. Akdaş N. İlter B. Öğüt Ö. Erdem



J Eur Acad Dermatol Venereol. 2021 Apr 29 com/doi/10.1111/jdv.17316

Categories: Coronavirus drugs

BNT162b2 mRNA Covid-19 Vaccine-induced chilblain-like lesions reinforces the hypothesis of their relationship with SARS-CoV-2

V. Piccolo, A. Bassi, G. Argenziano, C. Mazzatenta, M. Cutrone, I. Neri, R. Grimalt, T. Russo



J Eur Acad Dermatol Venereol. 2021 Apr 29 com/doi/10.1111/jdv.17320

Categories: Coronavirus drugs

Anaphylaxis to vaccination and polyethylene glycol (PEG): A perspective from the European Anaphylaxis Registry

M Kraft, JM Renaudin, LF Ensina, A Kleinheinz, MB Bilò, K Scherer Hofmeier, S Dölle-Bierke, M Worm



J Eur Acad Dermatol Venereol. 2021 Apr 29 doi/abs/10.1111/jdv.17327

Categories: Coronavirus drugs

Cutaneous adverse reactions after m-RNA COVID-19 vaccine: early reports from North-East Italy

E. Farinazzo, G. Ponis, E. Zelin, E. Errichetti, G. Stinco, C. Pinzani, A. Gambelli, N. De Manzini, L. Toffoli, A. Moret, M. Agozzino, C. Conforti, N. Di Meo, P. Schincariol, I. Zalaudek



J Eur Acad Dermatol Venereol. 2021 May 22 doi/abs/10.1111/jdv.17343

Categories: Coronavirus drugs

Pityriasis rosea-like eruptions following vaccination with BNT162b2 mRNA COVID-19 Vaccine

Benoit Cyrenne, Faisal Al-Mohammedi, Joel DeKoven, Raed Alhusayen



J Eur Acad Dermatol Venereol. 2021 May 13 com/doi/10.1111/jdv.17342

Categories: Coronavirus drugs

Purpuric lesions on the eyelids developed after BNT162b2 mRNA Covid-19 Vaccine: another piece of SARS-CoV-2 skin puzzle?

C. Mazzatenta, V. Piccolo, G. Pace, I. Romano, G. Argenziano, A. Bassi



J Eur Acad Dermatol Venereol. 2021 May 28 oi/full/10.1111/jdv.17340

Categories: Coronavirus drugs

Ipsilateral Herpes Zoster after the first dose of BNT162b2 mRNA COVID-19 vaccine

I. Tessas, N. Kluger



J Eur Acad Dermatol Venereol. 2021 May 31 oi/full/10.1111/jdv.17422

Categories: Coronavirus drugs

SARS-CoV-2 mRNA Vaccine-Associated Fixed Drug Eruption

Dillon Mintoff, David Pisani, Alexandra Betts, Lawrence Scerri



J Eur Acad Dermatol Venereol. 2021 May 25 com/doi/10.1111/jdv.17390

Categories: Coronavirus drugs

Immune thrombocytopenic purpura associated with COVID-19 Pfizer-BioNTech BNT16B2b2 mRNA vaccine

P. K. Krajewski, J. C. Szepietowski



J Eur Acad Dermatol Venereol. 2021 Jun 2 com/doi/10.1111/jdv.17444

Categories: Coronavirus drugs

Chilblain-like lesions after BNT162b2 mRNA COVID-19 vaccine: a case report suggesting that ‘COVID toes’ are due to the immune reaction to SARS-CoV-2

C. Lesort, J. Kanitakis, L. Donzier, D. Jullien



J Eur Acad Dermatol Venereol. 2021 Jun 16 com/doi/10.1111/jdv.17451

Categories: Coronavirus drugs

Systemic drug-related intertriginous and flexural exanthema like eruption after CoronaVac vaccine

O.M. Orenay, I. Balta, D. Yigit, M. Eksioglu



J Eur Acad Dermatol Venereol. 2021 Jun 17 oi/10.1111/jdv.17454?af=R

Categories: Coronavirus drugs

Psoriasis flare up associated with second dose of Pfizer-BioNTech BNT16B2b2 COVID-19 mRNA vaccine

P.K. Krajewski, Ł. Matusiak, J.C. Szepietowski



J Eur Acad Dermatol Venereol. 2021 Jun 16 com/doi/10.1111/jdv.17449

Categories: Coronavirus drugs

First dose of COVID-19 vaccine may trigger pemphigus and bullous pemphigoid flares: is the second dose contraindicated?

G. Damiani, A. Pacifico, F. Pelloni, M. Iorizzo



J Eur Acad Dermatol Venereol. 2021 Jun 25 com/doi/10.1111/jdv.17472

Categories: Coronavirus drugs

Delayed cutaneous reaction to ChAdOx1 nCoV-19 vaccine: Is it an ‘AstraZeneca arm’?

J.E. Kim, H. Lee, S.S. Paik, J.-Y. Moon, H.J. Yoon, S.-H. Kim



J Eur Acad Dermatol Venereol. 2021 Jun 24 com/doi/10.1111/jdv.17476

Categories: Coronavirus drugs

Development of severe pemphigus vulgaris following SARS-CoV-2 vaccination with BNT162b2

F. Solimani, Y. Mansour, D. Didona, A. Dilling, K. Ghoreschi, K. Meier



J Eur Acad Dermatol Venereol. 2021 Jun 25 com/doi/10.1111/jdv.17480

Categories: Coronavirus drugs

Pernio-like skin lesions after the second dose of Pfizer-BioNTech COVID-19 vaccine

N. Cameli, M. Silvestri, M. Mariano, S.P. Nisticò, A. Cristaudo



J Eur Acad Dermatol Venereol. 2021 Jul 8 com/doi/10.1111/jdv.17500

Categories: Coronavirus drugs

Transition of cutaneous into systemic lupus erythematosus following adenoviral vector-based SARS-CoV-2 vaccination

A. Kreuter, S.-N. Burmann, B. Burkert, F. Oellig, A.-L. Michalowitz



J Eur Acad Dermatol Venereol. 2021 Jul 9 oi/full/10.1111/jdv.17514

Categories: Coronavirus drugs

Widespread purpura annularis telangiectodes following mRNA SARS-CoV-2 vaccine

D. Falkenhain-López, C. Gutiérrez-Collar, J. Arroyo-Andrés, I. Gallego-Gutiérrez, J.L. Rodríguez-Peralto, A. Sánchez-Velázquez



J Eur Acad Dermatol Venereol. 2021 Jul 8 com/doi/10.1111/jdv.17497

Categories: Coronavirus drugs

‘COVID arm’ – histological features of a delayed-type hypersensitivity reaction to Moderna mRNA-1273 SARS-CoV2 vaccine

W. Kempf, N. Kettelhack, F. Kind, S. Courvoisier, J. Galambos, K. Pfaltz



J Eur Acad Dermatol Venereol. 2021 Jul 9 oi/full/10.1111/jdv.17506

Categories: Coronavirus drugs

Erythema multiforme after CoronaVac vaccination

N.T. Lopes, C.E.O. Pinilla, A.C. Gerbase



J Eur Acad Dermatol Venereol. 2021 Jul 8 com/doi/10.1111/jdv.17495

Categories: Coronavirus drugs

New onset of remitting seronegative symmetrical synovitis with pitting oedema and palmoplantar psoriasis flare-up after Sars-Cov-2 vaccination

L. Quattrini, L. Verardi, G. Caldarola, G. Peluso, C. De Simone, M. D’Agostino



J Eur Acad Dermatol Venereol. 2021 Jul 8 com/doi/10.1111/jdv.17502

Categories: Coronavirus drugs

Generalized eczematous reactions to the Pfizer-BioNTech COVID-19 vaccine

A.C. Leasure, S.E. Cowper, J. McNiff, J.M. Cohen



J Eur Acad Dermatol Venereol. 2021 Jul 8 com/doi/10.1111/jdv.17494

Categories: Coronavirus drugs

New-onset cutaneous lichen planus triggered by COVID-19 vaccination

R. Merhy, A.-S. Sarkis, J. Kaikati, L. El Khoury, S. Ghosn, F. Stephan



J Eur Acad Dermatol Venereol. 2021 Jul 8 oi/full/10.1111/jdv.17504

Categories: Coronavirus drugs

Pityriasis rosea developing after COVID-19 vaccination

O.Y. Marcantonio-Santa Cruz, A. Vidal-Navarro, D. Pesqué, A.M. Giménez-Arnau, R.M. Pujol, G. Martin-Ezquerra



J Eur Acad Dermatol Venereol. 2021 Jul 8 com/doi/10.1111/jdv.17498

Categories: Coronavirus drugs

Herpes Zoster following SARS-CoV-2 vaccination – a series of four cases

M. Alpalhão, P. Filipe



J Eur Acad Dermatol Venereol. 2021 Jul 26 com/doi/10.1111/jdv.17555

Categories: Coronavirus drugs

Small-vessel vasculitis following Oxford-AstraZeneca vaccination against SARS-CoV-2

L. Guzmán-Pérez, M. Puerta-Peña, D. Falkenhain-López, J. Montero-Menárguez, C. Gutiérrez-Collar, J.L. Rodríguez-Peralto, J. Sanz-Bueno



J Eur Acad Dermatol Venereol. 2021 Jul 26 com/doi/10.1111/jdv.17547

Categories: Coronavirus drugs

New-onset acral lesions on hands after administration of mRNA-1273 vaccine against SARS-CoV-2: clinical images and histopathological study of three cases

D. Revilla-Nebreda, M. Roncero-Riesco, Á. Santos-Briz, M. Medina-Migueláñez, N. Segurado-Tostón, C. Román-Curto



J Eur Acad Dermatol Venereol. 2021 Jul 26 oi/full/10.1111/jdv.17553

Categories: Coronavirus drugs

Small vessel vasculitis related to varicella-zoster virus after Pfizer-BioNTech COVID-19 vaccine

F. Nastro, G. Fabbrocini, F. di Vico, C. Marasca



J Eur Acad Dermatol Venereol. 2021 Jul 26 com/doi/10.1111/jdv.17550

Categories: Coronavirus drugs

Omalizumab prevents anaphylactoid reactions to mRNA COVID-19 vaccine

A. Smola, S. Samazadeh, L. Müller, O. Adams, B. Homey, P. Albrecht, S. Meller



J Eur Acad Dermatol Venereol. 2021 Jul 26 doi/abs/10.1111/jdv.17549

Categories: Coronavirus drugs

New onset of mainly guttate psoriasis after COVID-19 vaccination: a case report

M. Lehmann, P. Schorno, R.E. Hunger, K. Heidemeyer, L. Feldmeyer, N. Yawalkar



J Eur Acad Dermatol Venereol. 2021 Jul 26 com/doi/10.1111/jdv.17561

Categories: Coronavirus drugs

A skin reaction with rust-like discolouration to mRNA COVID-19 vaccine

R. Pasternack, S. Pohjavaara



J Eur Acad Dermatol Venereol. 2021 Jul 26 oi/full/10.1111/jdv.17543

Categories: Coronavirus drugs

Pityriasis rubra pilaris after Vaxzevria® COVID-19 vaccine

Iñigo Lladó, Beatriz Butrón-Bris, Raquel Sampedro-Ruiz, Javier Fraga, Diego de Argila



J Eur Acad Dermatol Venereol. 2021 Jul 26 com/doi/10.1111/jdv.17542

Categories: Coronavirus drugs

Cutaneous reactions to inactivated SARS-CoV-2 vaccine and ChAdOx1-S (recombinant) vaccine against SARS-CoV-2: a case series from the Philippines

J.N. Yu, C.B. Angeles, H.G. Lim, C. Chavez, C. Roxas-Rosete



J Eur Acad Dermatol Venereol. 2021 Aug 7 oi/full/10.1111/jdv.17575

Categories: Coronavirus drugs

Herpes zoster after ChAdOx1 nCoV-19 vaccine: a case series

M. Vastarella, V. Picone, F. Martora, G. Fabbrocini



J Eur Acad Dermatol Venereol. 2021 Aug 7 com/doi/10.1111/jdv.17576

Categories: Coronavirus drugs

Three cases of vesiculobullous non-IgE-mediated cutaneous reactions to tozinameran (Pfizer-BioNTech COVID-19 vaccine)

L. Juay, N.S. Chandran



J Eur Acad Dermatol Venereol. 2021 Aug 7 com/doi/10.1111/jdv.17581

Categories: Coronavirus drugs

Cutaneous reactions following CoronaVac COVID-19 vaccination: a case series of six healthcare workers from a single centre

E. Akdaş, B. Öğüt, Ö. Erdem, M.O. Öztaş, N. İlter



J Eur Acad Dermatol Venereol. 2021 Aug 9 oi/full/10.1111/jdv.17592

Categories: Coronavirus drugs

Rare cutaneous adverse effects of COVID-19 vaccines: a case series and review of the literature

E. Annabi,N. Dupin,P. Sohier,B. Garel,N. Franck,S. Aractingi,S. Guégan,B. Oulès



J Eur Acad Dermatol Venereol. 2021 Aug 7 doi.org/10.1111/jdv.17578

Categories: Coronavirus drugs

Herpes zoster after inactivated SARS-CoV-2 vaccine in two healthy young adults

A.K. Özdemir, S. Kayhan, S.K. Çakmak



J Eur Acad Dermatol Venereol. 2021 Aug 7 oi/full/10.1111/jdv.17577

Categories: Coronavirus drugs

Psoriasis exacerbation after COVID-19 vaccination: a report of 14 cases from a single centre

E. Sotiriou, A. Tsentemeidou, K. Bakirtzi, A. Lallas, D. Ioannides, E. Vakirlis



J Eur Acad Dermatol Venereol. 2021 Aug 7 com/doi/10.1111/jdv.17582

Categories: Coronavirus drugs

Erythema gyratum repens after COVID-19

R. Castro Silva, G. Castro Silva, M.C. Castro Silva, O. Lupi



J Eur Acad Dermatol Venereol. 2021 Aug 7 com/doi/10.1111/jdv.17583

Categories: Coronavirus drugs

A Bullous Eruption following the Pfizer-BioNTech COVID-19 vaccination

A. D’Cruz,H. Parker,M. Saha



J Eur Acad Dermatol Venereol. 2021 Aug 20 com/doi/10.1111/jdv.17606

Categories: Coronavirus drugs

Two cases of papulo-pustular rosacea-like eruptions following COVID-19 vaccinations

G. Ciccarese,F. Drago,A. Rebora,A. Parodi



J Eur Acad Dermatol Venereol. 2021 Aug 20 com/doi/10.1111/jdv.17615

Categories: Coronavirus drugs

‘COVID vaccine arm’ may present after both mRNA vaccines vaccination

S. Gregoriou,I. A. Kleidona,A. Tsimpidakis,E. Nicolaidou,A. Stratigos,D. Rigopoulos



J Eur Acad Dermatol Venereol. 2021 Aug 20 com/doi/10.1111/jdv.17614

Categories: Coronavirus drugs

Flagellate purpura associated with COVID-19 vaccination

E. Heck,B.D. Rankin,M. Schneider,V.H. Prajapati



J Eur Acad Dermatol Venereol. 2021 Aug 20 com/doi/10.1111/jdv.17609

Categories: Coronavirus drugs

Clinicopathological features of cutaneous reactions after mRNA-based COVID-19 vaccines

M. Tihy,S. Menzinger,R. André,E. Laffitte,L. Toutous-Trellu,G. Kaya



J Eur Acad Dermatol Venereol. 2021 Aug 30 com/doi/10.1111/jdv.17633

Categories: Coronavirus drugs

Two cases of pityriasis rosea after the injection of coronavirus disease 2019 vaccine

L. Huang, Z. Yao, J. Zhang



J Eur Acad Dermatol Venereol. 2021 Sep 7 oi/full/10.1111/jdv.17648

Categories: Coronavirus drugs

Varicella Zoster and Herpes Simplex Virus Reactivation Post-COVID-19 Vaccination: A Review of 40 Cases in an International Dermatology Registry

Ramie A. Fathy,Devon E. McMahon,Cynthia Lee,Grace C. Chamberlin,Misha Rosenbach,Jules B. Lipoff,Anisha Tyagi,Seemal R. Desai,Lars E. French,Henry W. Lim,Bruce H. Thiers,George J. Hruza,Marlys Fassett,Lindy P. Fox,Harry L. Greenberg,Kimberly Blumenthal,Esther E. Freeman



J Eur Acad Dermatol Venereol. 2021 Sep 6 com/doi/10.1111/jdv.17646

Categories: Coronavirus drugs

COVID vaccine-induced lichen planus on areas previously affected by vitiligo

Vincenzo Piccolo,Carlo Mazzatenta,Andrea Bassi,Giuseppe Argenziano,Mario Cutrone,Ramon Grimalt,Teresa Russo



J Eur Acad Dermatol Venereol. 2021 Sep 21 com/doi/10.1111/jdv.17687

Categories: Coronavirus drugs

Erythema multiforme after SARS-CoV-2 vaccine

Li-wen Zhang,Wen-ju Wang,Cong-hui Li,Tao Chen



J Eur Acad Dermatol Venereol. 2021 Sep 21 com/doi/10.1111/jdv.17689

Categories: Coronavirus drugs

New-onset and exacerbations of psoriasis after mRNA COVID-19 vaccines: two sides of the same coin?

David Pesqué,Emilio Lopez-Trujillo,Orianna Marcantonio,Ana Maria Giménez-Arnau,Ramon Maria Pujol



J Eur Acad Dermatol Venereol. 2021 Sep 21 com/doi/10.1111/jdv.17690

Categories: Coronavirus drugs

Eosinophilic cellulitis after BNT162b2 mRNA Covid-19 vaccine

Laurence de Montjoye,Liliane Marot,Marie Baeck



J Eur Acad Dermatol Venereol. 2021 Sep 21 com/doi/10.1111/jdv.17685

Categories: Coronavirus drugs

Pfizer-BioNTech SARS-CoV-2 mRNA Vaccine-associated Erythema Multiforme

Luca Borg,Liam Mercieca,Dillon Mintoff,Daniel Micallef,David Pisani,Alexandra Betts,Lawrence Scerri



J Eur Acad Dermatol Venereol. 2021 Sep 21 com/doi/10.1111/jdv.17682

Categories: Coronavirus drugs

Erythema nodosum, zoster duplex and pityriasis rosea as possible cutaneous adverse effects of Oxford–AstraZeneca COVID-19 vaccine: report of three cases from India

Hitaishi Mehta,Sanjeev Handa,Pankaj Malhotra,Meenakshi Patial,Smriti Gupta,Anirudh Mukherjee,Debajyoti Chatterjee,Aastha Takkar,Rahul Mahajan



J Eur Acad Dermatol Venereol. 2021 Sep 21 doi/abs/10.1111/jdv.17678

Categories: Coronavirus drugs

Early atypical injection-site reactions to COVID-19 vaccine: a case series

M. Vaccaro,L. Bertino,R. Squeri,C. Genovese,S. Isola,G. Spatari,E. Spina,P. Cutroneo



J Eur Acad Dermatol Venereol. 2021 Sep 21 com/doi/10.1111/jdv.17683

Categories: Coronavirus drugs

Nevocentric erythema multiforme after SARS-COV-2 Vaccine

C. Scharf,E. V. di Brizzi,S. Pellerone,M. Liguori,C.M.R. Giorgio,G. Argenziano



J Eur Acad Dermatol Venereol. 2021 Sep 21 com/doi/10.1111/jdv.17688

Categories: Coronavirus drugs

SARS-CoV-2 mRNA Vaccine Injection Site Pseudolymphoma

Dillon Mintoff,Lawrence Scerri,Alexandra Betts



J Eur Acad Dermatol Venereol. 2021 Sep 21 oi/10.1111/jdv.17680?af=R

Categories: Coronavirus drugs

A case of bullous pemphigoid after the SARS-CoV-2 mRNA vaccine

J. Young,L. Mercieca,M. Ceci,D. Pisani,A. Betts,M.J. Boffa



J Eur Acad Dermatol Venereol. 2021 Sep 21 com/doi/10.1111/jdv.17676

Categories: Coronavirus drugs

Recurrence of Cutaneous T-cell lymphoma (CTCL) post viral vector COVID-19 vaccination

E Panou,V Nikolaou,L Marinos,S Kallambou,P Sidiropoulou,M Gerochristou,A Stratigos,



J Eur Acad Dermatol Venereol. 2021 Oct 10 doi.org/10.1111/jdv.17736

Categories: Coronavirus drugs

Development of oral lichen planus after COVID-19 vaccination – a rare case report

P. Sharda, A. Mohta, B.C. Ghiya, R.D. Mehta



J Eur Acad Dermatol Venereol. 2021 Oct 4 oi/full/10.1111/jdv.17718

Categories: Coronavirus drugs

Eruptive angiomatosis after SARS-CoV-2 Vaccine (Comirnaty, Pfizer)

Corrado Zengarini,Cosimo Misciali,Tiziana Lazzarotto,Emi Dika,



J Eur Acad Dermatol Venereol. 2021 Oct 4 doi.org/10.1111/jdv.17723

Categories: Coronavirus drugs

Biphasic bullous pemphigoid starting after first dose and boosted by second dose of mRNA-1273 vaccine in an 84-year-old female with polymorbidity and polypharmacy

V. Schmidt,R. Blum,M. Möhrenschlager



J Eur Acad Dermatol Venereol. 2021 Oct 4 doi.org/10.1111/jdv.17722

Categories: Coronavirus drugs

Herpes zoster viral infection after AZD1222 and BNT162b2 coronavirus disease 2019 mRNA vaccines: a case series

D. Koumaki,S.-E. Krueger-Krasagakis,M. Papadakis,A. Katoulis,V. Koumaki,G. Evangelou,M. Stefanidou,D. Mylonakis,K. Zografaki,K. Krasagakis,



J Eur Acad Dermatol Venereol. 2021 Oct 4 doi.org/10.1111/jdv.17720

Categories: Coronavirus drugs

Pfizer/BioNTech-associated perniosis in two young adults with re-challenge evidence

S.G. Brooks,R. Alhusayen,V. Piguet,D. Croitoru,



J Eur Acad Dermatol Venereol. 2021 Oct 4 doi.org/10.1111/jdv.17719

Categories: Coronavirus drugs

Cutaneous findings following COVID-19 vaccination: Review of world literature and own experience

Thilo Gambichler,Stefanie Boms,Laura Susok,Heinrich Dickel,Cansu Finis,Nessr Abu Rached,Milan Barras,Markus Stücker,Dimitri Kasakovski,



J Eur Acad Dermatol Venereol. 2021 Oct 17 doi.org/10.1111/jdv.17744

Categories: Coronavirus drugs

Comment on “Development of eruptive pseudoangiomatosis following COVID-19 inmunization-apropos of 5 cases”: could eruptive pseudoangiomatosis represent a paraviral eruption associated with SARS-CoV-2?

Cristina Moya-Martinez,Emilio de Dios Berná-Rico,Ana Melian-Olivera,Carmen Moreno-Garcia del Real,Diego Fernández-Nieto,



J Eur Acad Dermatol Venereol. 2021 Oct 17 com/doi/10.1111/jdv.17750

Categories: Coronavirus drugs

Generalized erythema multiforme-like skin rash following the first dose of COVID-19 vaccine (Pfizer-BioNTech)

Minjae Kim,Jee Woo Kim,Minsu Kim,Sun Young Choi,Jung-Im Na,



J Eur Acad Dermatol Venereol. 2021 Oct 17 com/doi/10.1111/jdv.17757

Categories: Coronavirus drugs

Severe necrotizing myopathy after COVID-19 vaccine with BNT162b2 and regimen with ipilimumab plus nivolumab in a patient with advanced melanoma

Manon Blaise,Fanny Rocher,Hélène Spittler,Adrien Sanchez,Elisabeth Lanteri,Lucia Coco,Angela Puma,Arnaud Martel,Geraldine Gonfrier,Thierry Passeron,Henri Montaudié,



J Eur Acad Dermatol Venereol. 2021 Oct 17 doi.org/10.1111/jdv.17760

Categories: Coronavirus drugs

Cutaneous adverse reactions from 35,229 doses of Sinovac and AstraZeneca COVID-19 vaccination: A prospective cohort study in healthcare workers

Pawinee Rerknimitr,Thanaporn Puaratanaarunkon,Chanidapa Wongtada,Namthong Wittayabusarakam,Saran Krithin,Leilani Paitoonpong,Chanat Kumtornrut,Stephen J Kerr,Pravit Asawanonda,Watsamon Jantarabenjakul,Jettanong Klaewsongkram



J Eur Acad Dermatol Venereol. 2021 Oct 17 com/doi/10.1111/jdv.17761

Categories: Coronavirus drugs

Erythema nodosum following the first dose of ChAdOx1-S nCoV-19 vaccine

Norma Cameli,Martina Silvestri,Maria Mariano,Luigi Bennardo,Steven Paul Nisticò,Antonio Cristaudo,



J Eur Acad Dermatol Venereol. 2021 Oct 18 com/doi/10.1111/jdv.17762

Categories: Coronavirus drugs

Response to ‘A skin reaction with rust-like discolouration to mRNA COVID-19 vaccine

C Kouki,K Sellami,E Bahloul,M Amouri,A Masmoudi,H Turki,



J Eur Acad Dermatol Venereol. 2021 Oct 17 com/doi/10.1111/jdv.17751

Categories: Coronavirus drugs

Regression of common viral warts after ChAdOx1-S COVID-19 vaccine

Anna Płaszczyńska,Martyna Sławińska,Michał Sobjanek



J Eur Acad Dermatol Venereol. 2021 Oct 26 doi.org/10.1111/jdv.17771

Categories: Coronavirus drugs

Lymphomatoid drug reaction developed after BNT162b2 (Comirnaty) COVID-19 vaccine manifesting as pityriasis lichenoides et varioliformis acuta-like eruption

A. Sernicola,A. Dybala,V. Gomes,P. Maddalena,F. Adotti,G. Soda,R. Muharremi,P. Fino,E. Del Duca,T. Grieco



J Eur Acad Dermatol Venereol. 2021 Nov 9 doi.org/10.1111/jdv.17807

Categories: Coronavirus drugs

Eosinophilic dermatosis after AstraZeneca COVID-19 vaccination

E. Cinotti,J.-L. Perrot,F. Bruzziches,L. Tognetti,A. Batsikosta,E. Sorrentino,A.V. Marzano,P. Rubegni



J Eur Acad Dermatol Venereol. 2021 Nov 9 doi.org/10.1111/jdv.17806

Categories: Coronavirus drugs

Reply to “New-onset cutaneous lichen planus triggered by COVID-19 vaccination” by Merhy et al.

E. Camela,G. Guerrasio,C. Patruno,M. Scalvenzi,N. Di Caprio,G. Fabbrocini,M. Napolitano



J Eur Acad Dermatol Venereol. 2021 Dec 11 doi.org/10.1111/jdv.17866

Categories: Coronavirus drugs

Emergence of Behçet’s disease post-SARS-CoV2-vaccination: two clinical cases in Japan

H. Hashizume,S. Ajima,Y. Ishikawa



J Eur Acad Dermatol Venereol. 2021 Dec 11 doi.org/10.1111/jdv.17859

Categories: Coronavirus drugs

Development of pemphigus vulgaris following mRNA SARS-CoV-19 BNT162b2 vaccination in an 89-year-old patient

G.V. Knechtl,S.M. Seyed Jafari,T. Berger,A. Rammlmair,L. Feldmeyer,L. Borradori



J Eur Acad Dermatol Venereol. 2021 Dec 12 doi.org/10.1111/jdv.17868

Categories: Coronavirus drugs

Exuberant lichenoid eruption after Oxford–AstraZeneca COVID-19 vaccine: a singular case

C. Correia,S. Fernandes,L. Soares-de-Almeida,P. Filipe



J Eur Acad Dermatol Venereol. 2021 Dec 16 doi.org/10.1111/jdv.17872

Categories: Coronavirus drugs

Extensive cutaneous lichen planus triggered by viral vector COVID-19 vaccination (ChAdOx1 nCoV-19)

C. Masseran,A. Calugareanu,F. Caux,G. Bohelay



J Eur Acad Dermatol Venereol. 2021 Dec 21 doi.org/10.1111/jdv.17899

Categories: Coronavirus drugs

Lichen planus after CoronaVac: a rare complication of vaccines 

A. Satılmış Kaya,N. Cemşitoğlu,E. Adışen,Ö. Erdem



J Eur Acad Dermatol Venereol. 2022 Jan 6 doi.org/10.1111/jdv.17906

Categories: Coronavirus drugs

Bullous pemphigoid in a young male after COVID-19 mRNA vaccine: a report and brief literature review

M. Pauluzzi,G. Stinco,E. Errichetti



J Eur Acad Dermatol Venereol. 2021 Dec 20 doi.org/10.1111/jdv.17891

Categories: Coronavirus drugs

Cutaneous manifestations following COVID-19 vaccination: a multicentric descriptive cohort

E. Massip,P. Marcant,G. Font,S. Faiz,S. Duvert-Lehembre,I. Alcaraz,A. Vermersch-Langlin,M. Véron,C. Macaire,K. Faure,F. Vuotto,D. Staumont-Sallé,F. Dezoteux



J Eur Acad Dermatol Venereol. 2021 Dec 20 doi.org/10.1111/jdv.17883

Categories: Coronavirus drugs

SCLE manifestation after mRNA COVID-19 vaccination

L. Rechtien,C. Erfurt-Berge,M. Sticherling



J Eur Acad Dermatol Venereol. 2021 Dec 20 doi.org/10.1111/jdv.17895

Categories: Coronavirus drugs

Genital necrosis with cutaneous thrombosis after COVID-19 mRNA vaccination

A. Kuzumi,A. Yoshizaki,K. Chiba,S. Mitsuo,K.M. Matsuda,Y. Norimatsu,K. Nagai,J. Omatsu,T. Miyake,S. Sato



J Eur Acad Dermatol Venereol. 2021 Nov 28 doi.org/10.1111/jdv.17837

Categories: Coronavirus drugs

Koebner phenomenon with lichen planus in an area of previous vitiligo after COVID-19 vaccination and the creation of a locus minoris resistentiae

A.L. Tatu,T. Nadasdy,L.C. Nwabudike



J Eur Acad Dermatol Venereol. 2021 Dec 11 doi.org/10.1111/jdv.17864

Categories: Coronavirus drugs

Eosinophilic panniculitis: a new side effect of Sinopharm COVID-19 vaccine

J. Kaikati,A. Ghanem,R. El Bahtimi,J. Helou,R. Tomb



J Eur Acad Dermatol Venereol. 2022 Jan 12 doi.org/10.1111/jdv.17920

Categories: Coronavirus drugs

COVID vaccine-induced pustular psoriasis in patients with previous plaque type psoriasis

V. Piccolo,T. Russo,C. Mazzatenta,A. Bassi,G. Argenziano,M. Cutrone,M. E. S. Danielsson Darlington,R. Grimalt



J Eur Acad Dermatol Venereol. 2022 Jan 11 doi.org/10.1111/jdv.17918

Categories: Coronavirus drugs

COVID vaccine-induced reaction around molluscum contagiosum with secondary partial clearance of lesions

V. Piccolo,A. Bassi,C. Mazzatenta,G. Argenziano,M. Cutrone,R. Grimalt,T. Russo



J Eur Acad Dermatol Venereol. 2022 Jan 12 doi.org/10.1111/jdv.17919

Categories: Coronavirus drugs

Stevens-Johnson Syndrome induced by Vaxvetria (AZD1222) Covid-19 vaccine

C. Aimo,E.B. Mariotti,A. Corrà,E. Cipollini,O. Le Rose,C. Serravalle,N. Pimpinelli,M. Caproni



J Eur Acad Dermatol Venereol. 2022 Feb 08 doi.org/10.1111/jdv.17988

Categories: Coronavirus drugs

Pityriasis Lichenoides et Varioliformis Acuta Following COVID-19 mRNA Vaccination

J. Palmén,M. Lepistö,L. Talve,N. Hieta



J Eur Acad Dermatol Venereol. 2022 Jan 11 doi.org/10.1111/jdv.17912

Categories: Coronavirus drugs

Cutaneous Reactions due to Pfizer’s BNT162b2 mRNA and Moderna’s mRNA-1273 Vaccines

A. Oulee,S. Salem,R. Yahia,K. Yang,D. Garcia,A. Holmes,B. Furukawa



J Eur Acad Dermatol Venereol. 2022 Jan 13 doi.org/10.1111/jdv.17925

Categories: Coronavirus drugs

Wells’ syndrome following Oxford–AstraZeneca COVID-19 vaccination

Y. H. Kim,Y. C. Kim



J Eur Acad Dermatol Venereol. 2022 Jan 11 doi.org/10.1111/jdv.17916

Categories: Coronavirus drugs

Trigger of Type 2 Lepra reaction with acute foot drop following Covid-19 vaccination.

A.K. Panda,F. Begum,M. Panda,A.K. Jena



J Eur Acad Dermatol Venereol. 2022 Jan 11 doi.org/10.1111/jdv.17915

Categories: Coronavirus drugs

Psoriasis flare-up after AZD1222 and BNT162b2 COVID-19 mRNA vaccines: report of twelve cases from a single centre.

D. Koumaki,S.-E. Krueger-Krasagakis,M. Papadakis,A.C. Katoulis,I. Gkiaouraki,K. Zografaki,D. Mylonakis,K. Krasagakis



J Eur Acad Dermatol Venereol. 2022 Jan 24 doi.org/10.1111/jdv.17965

Categories: Coronavirus drugs

Reply to “The first dose of COVID-19 vaccine may trigger pemphigus and bullous pemphigoid flares: is the second dose therefore contraindicated?” by Damiani G et al.

G. Avallone,S. Giordano,C. Astrua,M. Merli,R. Senetta,C. Conforti,S. Ribero,A.V. Marzano,P. Quaglino



J Eur Acad Dermatol Venereol. 2022 Jan 23 doi.org/10.1111/jdv.17959

Categories: Coronavirus drugs

A first case of “Covid toes” from a viral vector-based COVID-19 vaccine.

A. Van Loon,D. Mortelmans,V. Siozopoulou,B. Ogunjimi,H. Jansens,J. Lambert,O. Aerts



J Eur Acad Dermatol Venereol. 2022 Jan 23 doi.org/10.1111/jdv.17948

Categories: Coronavirus drugs

Cutaneous arteritis following mRNA-1273 Moderna COVID-19 vaccination

T. Ogawa,U. Aitake,T. Nomura



J Eur Acad Dermatol Venereol. 2022 Jan 23 doi.org/10.1111/jdv.17947

Categories: Coronavirus drugs

A study of COVID-19 vaccine (Covishield) induced dermatological adverse effects from India

P. Das,S. Arora,G.K. Singh,P. Bellad,R. Rahman,A. Bahuguna,D. Sapra,R. Shrivastav,A. Gupta



J Eur Acad Dermatol Venereol. 2022 Jan 24 doi.org/10.1111/jdv.17951

Categories: Coronavirus drugs

Incident bullous pemphigoid in a psoriatic patient following mRNA-1273 SARS-CoV-2 vaccination

W.-K. Hung,C.-C. Chi



J Eur Acad Dermatol Venereol. 2022 Jan 24 doi.org/10.1111/jdv.17955

Categories: Coronavirus drugs

“COVID nose” - a unique post-COVID pigmentary sequelae reminiscing Chik sign: a descriptive case series

A. Sil,A. Panigrahi,A. Chandra,J.D. Pramanik



J Eur Acad Dermatol Venereol. 2022 Feb 08 doi.org/10.1111/jdv.17989

Categories: Coronavirus drugs

Reply to “COVID vaccine-induced lichen planus on areas previously affected by vitiligo”

E. Bularca,J. Monte-Serrano,P. Villagrasa-Boli,A. Lapeña-Casado,S. de-la-Fuente



J Eur Acad Dermatol Venereol. 2022 Feb 11 doi.org/10.1111/jdv.18001

Categories: Coronavirus drugs

Development of eruptive pseudoangiomatosis following immunization with COVISHIELD vaccine in an adult

T. Prarthana,S. Bakshi,V. Hanumanthu,U. Nahar,D. De



J Eur Acad Dermatol Venereol. 2022 Feb 08 doi.org/10.1111/jdv.17990

Categories: Coronavirus drugs

Subacute cutaneous lupus erythematosus induction after SARS-CoV-2 Vaccine in a patient with primary biliary cholangitis

C. Zengarini,A. Pileri,F.P. Salamone,B.M. Piraccini,G. Vitale,M. La Placa



J Eur Acad Dermatol Venereol. 2021 Nov 22 doi.org/10.1111/jdv.17827

Categories: Coronavirus drugs

Not only toes and fingers: COVID vaccine-induced chilblain-like lesions of the knees

A. Bassi,C. Mazzatenta,A. Sechi,M. Cutrone,V. Piccolo



J Eur Acad Dermatol Venereol. 2022 Feb 21 doi.org/10.1111/jdv.18025

Categories: Coronavirus drugs

A case of psoriatic spondyloarthritis exacerbation triggered by COVID-19 messenger RNA vaccine

S. Ohmura,S. Hanai,R. Ishihara,Y. Ohkubo,T. Miyamoto



J Eur Acad Dermatol Venereol. 2022 Feb 17 doi.org/10.1111/jdv.18013

Categories: Coronavirus drugs

Unilateral linear purpuric rash heralding SARS-CoV-2 vaccine-induced immune thrombotic thrombocytopenia

Y.-T. Hung,Y.-L. Huang,Y.-Y. Chang,W.-T. Chen



J Eur Acad Dermatol Venereol. 2022 Feb 17 doi.org/10.1111/jdv.18014

Categories: Coronavirus drugs

Pityriasis lichenoides et varioliformis acuta after SARS-CoV-2 infection and relapse after vaccination

T. Mäkilä,L. Jeskanen,M. Butina,L. Harjama,A. Ranki,T. Mälkönen,N. Kluger



J Eur Acad Dermatol Venereol. 2022 Feb 19 doi.org/10.1111/jdv.18024

Categories: Coronavirus drugs

Generalized pustular psoriasis flare in a patient affected by plaque psoriasis after BNT162b2 mRNA COVID-19 vaccine, successfully treated with risankizumab

G. Pavia,L. Gargiulo,F. Spinelli,J. Avagliano,M. Valenti,R. G. Borroni,A. Costanzo,A. Narcisi



J Eur Acad Dermatol Venereol. 2022 Feb 27 doi.org/10.1111/jdv.18032

Categories: Coronavirus drugs

Association between vaccination and immunobullous disorders: a brief, updated systematic review with focus on COVID-19

M. Kasperkiewicz,D.T. Woodley



J Eur Acad Dermatol Venereol. 2022 Feb 26 doi.org/10.1111/jdv.18030

Categories: Coronavirus drugs

Erythema nodosum leprosum post-COVID-19 vaccination: endemic while pandemic

T. Fachler,K. Olshtain-Pops,L. Horev



J Eur Acad Dermatol Venereol. 2022 Feb 28 doi.org/10.1111/jdv.18035

Categories: Coronavirus drugs

Pityriasis rubra pilaris (type I) following ChAdOx1 COVID-19 vaccine: A report of two cases with successful treatment with oral isotretinoin

P.R. Criado,M. Ianhez,P.S. Rocha,H.A. Miot



J Eur Acad Dermatol Venereol. 2022 Mar 12 doi.org/10.1111/jdv.18055

Categories: Coronavirus drugs

Erythema gyratum repens after COVID vaccination

D. Chiquito,J.C.C. Xavier-Junior,G. Peres,O. Lupi



J Eur Acad Dermatol Venereol. 2022 Mar 11 doi.org/10.1111/jdv.18061

Categories: Coronavirus drugs

Another case of generalized bullous fixed drug eruption following an adenoviral vector-based COVID-19 vaccine (ChAdOx1 nCov-19)

C. Ben Salem,A. Khelif,D. Sahnoun,N. Ghariani,B. Sriha,M. Denguezli



J Eur Acad Dermatol Venereol. 2022 Mar 11 doi.org/10.1111/jdv.18059

Categories: Coronavirus drugs

Case of lichen planus pigmentosus–inversus after Oxford–AstraZeneca COVID-19 vaccine: cause or coincidence?

L. Sun,S. Duarte,L. Soares-de-Almeida



J Eur Acad Dermatol Venereol. 2022 Mar 12 doi.org/10.1111/jdv.18058

Categories: Coronavirus drugs

Two cases of anti-TIF1-γ antibody positive dermatomyositis with manifested symptoms after SARS-CoV-19 vaccination

A. Yoshida,T. Ikegami,K. Igawa



J Eur Acad Dermatol Venereol. 2022 Mar 11 doi.org/10.1111/jdv.18060

Categories: Coronavirus drugs

Erythema multiforme in COVID-19 patients and following COVID-19 vaccination: manifestations, associations and outcomes

F. Etaee,M. Eftekharian,T. Naguib,S. Daveluy



J Eur Acad Dermatol Venereol. 2022 Mar 11 doi.org/10.1111/jdv.18063

Categories: Coronavirus drugs

Symmetrical drug-related intertriginous and flexural exanthema-like eruption after COVID-19 vaccine

I. Lahouel,N. Ben Salah,N. Ben Fadhel,F. Chahed,N. Ouni,H. Belhadjali,K. Aouem,J. Zili



J Eur Acad Dermatol Venereol. 2022 Mar 28 doi.org/10.1111/jdv.18108

Categories: Coronavirus drugs

Transient inflammation in surgical scars following Covid-19 mRNA vaccination

C. Ferreli,J. Anedda,L. Atzori



J Eur Acad Dermatol Venereol. 2022 Mar 19 doi.org/10.1111/jdv.18088

Categories: Coronavirus drugs

De novo annular pustular psoriasis following mRNA COVID-19 vaccine

M. Romagnuolo,P. Pontini,S. Muratori,A. V. Marzano,C. Moltrasio



J Eur Acad Dermatol Venereol. 2022 Mar 29 doi.org/10.1111/jdv.18114

Categories: Coronavirus drugs

Commentary on ‘Psoriasis flare-up associated with second dose of Pfizer-BioNTech BNT16B2b2 COVID-19 mRNA vaccine’

D. Turkmen,N. Altunisik



J Eur Acad Dermatol Venereol. 2022 Mar 30 doi.org/10.1111/jdv.18117

Categories: Coronavirus drugs

Rare cutaneous reactions after ChAdOx1 (Oxford-AstraZeneca) vaccine: 12 case series from Brazil

C.A. Seque,M.M.S.S. Enokihara,M.M. Nascimento,A.M. Porro,J. Tomimori



J Eur Acad Dermatol Venereol. 2022 Mar 29 doi.org/10.1111/jdv.18112

Categories: Coronavirus drugs

Haemorrhagic bullous pyoderma gangrenosum following COVID-19 vaccination

Y.-T. Hung,W.-H. Chung,T.-F. Tsai,C.-B. Chen



J Eur Acad Dermatol Venereol. 2022 Apr 10 doi.org/10.1111/jdv.18132

Categories: Coronavirus drugs

Two cases of axillary lymphadenopathy diagnosed as diffuse large B-cell lymphoma developed shortly after BNT162b2 COVID-19 vaccination

M. Mizutani,H. Mitsui,T. Amano,Y. Ogawa,N. Deguchi,S. Shimada,A. Miwa,T. Kawamura,Y. Ogido



J Eur Acad Dermatol Venereol. 2022 Apr 10 doi.org/10.1111/jdv.18136

Categories: Coronavirus drugs

SARS-CoV-2 mRNA booster vaccine-associated lichenoid drug eruption

D. Mintoff,D. Pisani,N. Livori,I. Said-Huntingford,G. Baldacchino



J Eur Acad Dermatol Venereol. 2022 Apr 16 doi.org/10.1111/jdv.18149

Categories: Coronavirus drugs

Cutaneous adverse effects of the available COVID-19 vaccines in India: a questionnaire-based study

J. Bawane,R. Kataria,A. Mohite,K. Verma,U. Shukla



J Eur Acad Dermatol Venereol. 2022 Apr 16 doi.org/10.1111/jdv.18150

Categories: Ocupational skin disease, including effects of PPE

Dermatology staff participate in fight against Covid-19 in China.

Zheng Y, Lai W.



J Eur Acad Dermatol Venereol. 2020 Mar 23. doi: 10.1111/jdv.16390.

Categories: Ocupational skin disease, including effects of PPE

Skin reactions to non-glove personal protective equipment: An emerging issue in the COVID-19 pandemic.

Gheisari M, Araghi F, Moravvej H, Tabary M, Dadkhahfar S.



J Eur Acad Dermatol Venereol. 2020 Apr 17. doi: 10.1111/jdv.16492.

Categories: Ocupational skin disease, including effects of PPE

Covid-19: Countermeasure for N95 mask-induced pressure sore.

Yin Z.



J Eur Acad Dermatol Venereol. 2020 Apr 17. doi: 10.1111/jdv.16490.

Categories: Ocupational skin disease, including effects of PPE

Hand disinfection in the combat against Covid-19.

Goldust M, Abdelmaksoud A, Navarini AA.



J Eur Acad Dermatol Venereol. 2020 May 3. doi: 10.1111/jdv.16574.

Categories: Ocupational skin disease, including effects of PPE

COVID-19 epidemic: Skin protection for health care workers must not be ignored.

Zhang B, Zhai R, Ma L.



J Eur Acad Dermatol Venereol. 2020 May 2. doi: 10.1111/jdv.16573.

Categories: Ocupational skin disease, including effects of PPE

Occupational skin conditions on the frontline: A survey among 484 Chinese healthcare professionals caring for Covid-19 patients.

Pei S, Xue Y, Zhao S, Alexander N, Mohamad G, Chen X, Yin M.



J Eur Acad Dermatol Venereol. 2020 May 3. doi: 10.1111/jdv.16570.

Categories: Ocupational skin disease, including effects of PPE

Localised mid-face miliaria as a consequence of filtering face piece (FFP) respirator use during the COVID-19 pandemic.

Campbell V, Middleton D, Donnelly J, Hunter H.



J Eur Acad Dermatol Venereol. 2020 May 9. doi: 10.1111/jdv.16624. 

Categories: Ocupational skin disease, including effects of PPE

Personal protective equipment induced facial dermatoses in healthcare workers managing COVID-19 cases.

Singh M, Pawar M, Bothra A, Maheshwari A, Dubey V, Tiwari A, Kelati A.



J Eur Acad Dermatol Venereol. 2020 May 12. doi: 10.1111/jdv.16628. 

Categories: Ocupational skin disease, including effects of PPE

Efficacy of hydrogel patches in preventing facial skin damage caused by mask compression in fighting against coronavirus disease-2019: a short-term, self-controlled study.

Dong L, Yang L, Li Y, Yang J, An X, Yang L, Zhou N, Zhang Y, Du H, Lan J, Song Z, Miao X, Zhu J, Tao J.



J Eur Acad Dermatol Venereol. 2020 May 18. doi: 10.1111/jdv.16638.

Categories: Occupational and nosocomial skin disease, including effects of PPE

Protecting medical staff from skin injury/disease caused by personal protective equipments during epidemic period of COVID-19: experience from China

H. Long, H. Zhao, Z. Yao, B. Cheng, Q. Lu



J Eur Acad Dermatol Venereol 2020; May 22 doi.org/10.1111/jdv.16388

Categories: Occupational and nosocomial skin disease, including effects of PPE

Hand Eczema Pandemic Caused by COVID-19 Hygiene Measures: The Setup of a Hand Eczema Helpline for Hospital Personnel

K. Greveling, A.C.M. Kunkeler



J Eur Acad Dermatol Venereol 2020 June 2 doi.org/10.1111/jdv.16695

Categories: Occupational and nosocomial skin disease, including effects of PPE

Retroauricular dermatitis with vehement use of ear loop face masks during COVID‐19 pandemic

Bothra A, Das S, Singh M, Pawar M, Maheswari A.



J Eur Acad Dermatol Venereol. 2020 Jun 3. doi: 10.1111/jdv.16692.

Categories: Occupational and nosocomial skin disease, including effects of PPE

Occupational skin disease during the COVID-19 pandemic, as captured in a Dermatology staff clinic in the United Kingdom

Hadjieconomou S, Hughes J, Kamath S.



J Eur Acad Dermatol Venereol. 2020 Jun 14. doi: 10.1111/jdv.16754.

Categories: Occupational and nosocomial skin disease, including effects of PPE

Symmetric chest pressure ulcers, consequence of prone position ventilation in a patient with COVID-19.

Martínez Campayo N, Bugallo Sanz JI, Mosquera Fajardo I.



J Eur Acad Dermatol Venereol. 2020 Jun 15. doi: 10.1111/jdv.16755.

Categories: Occupational and nosocomial skin disease, including effects of PPE

How the use of surgical masks during COVID-19 pandemic can induce skin effects

Veronese S, Bernardi P, Sbarbati A.



J Eur Acad Dermatol Venereol. 2020 Sep 1. doi: 10.1111/jdv.16905.

Categories: Occupational and nosocomial skin disease, including effects of PPE

Occupational dermatoses from PPE during the COVID-19 pandemic in the tropics – A review.

Lee HC, Goh CL.



J Eur Acad Dermatol Venereol. 2020 Sep 7. doi: 10.1111/jdv.16925.

Categories: Occupational and nosocomial skin disease, including effects of PPE

Adverse skin reactions following different types of mask usage during the COVID-19 pandemic

C. Chaiyabutr T. Sukakul C. Pruksaeakanan J. Thumrongtharadol W. Boonchai



J Eur Acad Dermatol Venereol. 2020 Nov 21 doi.org/10.1111/jdv.17039

Categories: Occupational and nosocomial skin disease, including effects of PPE

ADVERSE SKIN REACTIONS RELATED TO PPE AMONG HEALTH CARE WORKERS MANAGING COVID-19

Priyanka Sharma Nainika Goel Kanika Dogar Mala Bhalla GP Thami Kavita Punia



J Eur Acad Dermatol Venereol. 2021 Apr 18 doi.org/10.1111/jdv.17290

Categories: Occupational and nosocomial skin disease, including effects of PPE

Adverse Skin Reactions Due to Use of Face Masks: A Prospective Survey during the COVID-19 Pandemic in Korea

S.J. Park, H.S. Han, S.H. Shin, K.H. Yoo, K. Li, B.J. Kim, S.J. Seo, K.Y. Park



J Eur Acad Dermatol Venereol. 2021 Jun 15 com/doi/10.1111/jdv.17447

Categories: Occupational and nosocomial skin disease, including effects of PPE

Dermatoses caused by face mask wearing during the COVID-19 pandemic

O.Yu. Olisova, N.P. Teplyuk, E.V. Grekova, A.A. Lepekhova



J Eur Acad Dermatol Venereol. 2021 Jul 26 oi/full/10.1111/jdv.17546

Categories: Occupational and nosocomial skin disease, including effects of PPE

Characteristics of facial skin problems and microbiome variation during wearing masks for fighting against COVID-19

C. Huang, Q. Sun, D. Jiang, X. Zhang, C. Chen, D. Yan, X. Liu, Y. Zhou, C. Ding, L. Lan, J. Wu, L. Li, A. Li, X. Liu, S. Yang



J Eur Acad Dermatol Venereol. 2021 Aug 7 oi/full/10.1111/jdv.17580

Categories: Occupational and nosocomial skin disease, including effects of PPE

Personal protective equipment use and face acne in health care providers during the COVID-19 pandemic in Romania: a new occupational acne type?

S Cretu,M Dascalu,SR Georgescu,CM Salavastru



J Eur Acad Dermatol Venereol. 2021 Sep 21 com/doi/10.1111/jdv.17679

Categories: Occupational and nosocomial skin disease, including effects of PPE

Reply to “Dermatoses caused by face mask wearing during the COVID-19 pandemic”

F. Bardazzi,L. Sacchelli,C. Loi,F. Filippi,A. Guglielmo



J Eur Acad Dermatol Venereol. 2022 Feb 17 doi.org/10.1111/jdv.18012

Categories: Occupational and nosocomial skin disease, including effects of PPE

Maskne prevalence and associated factors in Irish healthcare workers during the COVID-19 pandemic

L.F. Kiely,C. O'Connor,G. O’Briain,C. O’Briain,J. Gallagher,J.F. Bourke



J Eur Acad Dermatol Venereol. 2022 Mar 12 doi.org/10.1111/jdv.18054

Categories: Specific diseases and patient groups

European Task Force on Atopic Dermatitis (ETFAD) statement on severe acute respiratory syndrome coronavirus 2 (SARS‐Cov‐2)‐infection and atopic dermatitis.

Wollenberg A, Flohr C, Simon D, Cork MJ, Thyssen JP, Bieber T, de Bruin-Weller MS, Weidinger S, Deleuran M, Taieb A, Paul C, Trzeciak M, Werfel T, Seneschal J, Barbarot S, Darsow U, Torrelo A, Stalder JF, Svensson Å, Hijnen D, Gelmetti C, Szalai Z, Gieler U, De Raeve L, Kunz B, Spuls P, von Kobyletzki LB, Fölster-Holst R, Chernyshov PV, Cristen-Zaech S, Heratizadeh A, Ring J, Vestergaard C



J Eur Acad Dermatol Venereol. 2020 Mar 29. doi: 10.1111/jdv.16411.

Categories: Specific diseases and patient groups

Expert recommendations for the management of autoimmune bullous diseases during the COVID-19 pandemic.

Kasperkiewicz M, Schmidt E, Fairley JA, Joly P, Payne AS, Yale ML, Zillikens D, Woodley DT.



J Eur Acad Dermatol Venereol. 2020 Apr 25. doi: 10.1111/jdv.16525.

Categories: Specific diseases and patient groups

Skin cancer triage and management during COVID-19 pandemic.

Tagliaferri L, Di Stefani A, Schinzari G, Fionda B, Rossi E, Del Regno L, Gentileschi S, Federico F, Valentini V, Tortora G, Peris K; Gemelli Skin-Cancer Multidisciplianry Tumour Board (S-MDTB).



J Eur Acad Dermatol Venereol. 2020 Apr 25. doi: 10.1111/jdv.16529.

Categories: Specific diseases and patient groups

Psoriasis health care in the time of the coronavirus pandemic: insights from dedicated centers in Sardinia (Italy).

Atzori L, Mugheddu C, Addis G, Sanna S, Satta R, Ferreli C, Atzori MG, Montesu MA, Rongioletti F.



J Eur Acad Dermatol Venereol. 2020 Apr 15. doi: 10.1111/jdv.16473.

Categories: Specific diseases and patient groups

Estimated effect of COVID-19 lockdown on melanoma thickness and prognosis: a rate of growth model.

Tejera-Vaquerizo A, Nagore E.



J Eur Acad Dermatol Venereol. 2020 May 2. doi: 10.1111/jdv.16555.

Categories: Specific diseases and patient groups

Metastatic melanoma treatment with check point inhibitors in the COVID-19 era: experience from an Italian Skin Cancer Unit.

Quaglino P, Fava P, Brizio M, Marra E, Rubatto M, Agostini A, Tonella L, Ribero S, Fierro MT.



J Eur Acad Dermatol Venereol. 2020 May 19. doi: 10.1111/jdv.16586.

Categories: Specific diseases and patient groups

European Task Force on Contact Dermatitis statement on coronavirus 19 disease (COVID-19) outbreak and the risk of adverse cutaneous reactions.

Balato A, Ayala F, Bruze M, Crepy MN, Gonçalo M, Duus Johansen J, John SM, Pigatto P, Raimondo A, Rustemeyer T, Schuttelaar MA, Svedman C, Aerst O, Uter W, Wilkinson M, Gimenez-Arnau A.



J Eur Acad Dermatol Venereol. 2020 Apr 30. doi: 10.1111/jdv.16557.

Categories: Specific diseases and patient groups

Management of primary cutaneous lymphoma patients during COVID-19 pandemic: EORTC CLTF guidelines.

Papadavid E, Scaribrick J, Ortiz Romero P, Guaglino P, Vermeer M, Knobler R, Stadler R, Bagot M.



J Eur Acad Dermatol Venereol. 2020 May 16. doi: 10.1111/jdv.16593.

Categories: Specific diseases and patient groups

Occurrence of SARS-CoV-2 during mycophenolate mofetil treatment for pemphigus.

Balestri R, Rech G, Girardelli CR.



J Eur Acad Dermatol Venereol. 2020 May 2. doi: 10.1111/jdv.16578.

Categories: Specific diseases and patient groups

COVID-19 pulmonary infection in erythrodermic psoriatic patient with oligodendroglioma: safety and compatibility of apremilast with critical intensive care management.

Mugheddu C, Pizzatti L, Sanna S, Atzori L, Rongioletti F.



J Eur Acad Dermatol Venereol. 2020 May 9. doi: 10.1111/jdv.16625.

Categories: Specific diseases and patient groups

COVID-19 pulmonary infection in erythrodermic psoriatic patient with oligodendroglioma: safety and compatibility of apremilast with critical intensive care management.

Mugheddu C, Pizzatti L, Sanna S, Atzori L, Rongioletti F.



J Eur Acad Dermatol Venereol. 2020 May 9. doi: 10.1111/jdv.16625.

Categories: Specific diseases and patient groups

Treatment adherence in psoriatic patients during COVID-19 pandemic: Real-world data from a tertiary hospital in Greece

Vakirlis AE, Bakirtzi K, Papadimitriou I, Vrani F, Sideris N, Lallas A, Ioannides D, Sotiriou E.



J Eur Acad Dermatol Venereol. 2020 Jun 18. doi: 10.1111/jdv.16759.

Categories: Specific diseases and patient groups

Drug reaction with eosinophilia and systemic symptoms syndrome in a patient with COVID-19

Herman A, Matthews M, Mairlot M, Nobile L, Fameree L, Jacquet LM, Baeck M.



J Eur Acad Dermatol Venereol. 2020 Jul 31. doi: 10.1111/jdv.16838.

Categories: Specific diseases and patient groups

Severe COVID-19 outcomes in patients with psoriasis

Lima XT, Cueva MA, Lopes EM, Alora MB.



J Eur Acad Dermatol Venereol. 2020 Aug 11. doi: 10.1111/jdv.16867. 

Categories: Specific diseases and patient groups

Scabies outbreak during home confinement due to the SARS-CoV-2 pandemic

Martínez-Pallás I, Aldea-Manrique B, Ramírez-Lluch M, Vinuesa-Hernando JM, Ara-Martín M.



J Eur Acad Dermatol Venereol. 2020 Aug 18. doi: 10.1111/jdv.16879.

Categories: Specific diseases and patient groups

Concerns related to the COVID-19 pandemic in adult patients with atopic dermatitis and psoriasis treated with systemic immunomodulatory therapy: a Danish questionnaire survey

Dyrberg Loft N, Halling AS, Iversen L, Vestergaard C, Deleuran M, Rasmussen MK, Zachariae C, Thyssen JP, Skov L.



J Eur Acad Dermatol Venereol. 2020 Aug 11. doi: 10.1111/jdv.16863. 

Categories: Specific diseases and patient groups

DELAYED MELANOMA DIAGNOSIS IN THE COVID-19 ERA: INCREASED BRESLOW THICKNESS IN PRIMARY MELANOMAS SEEN AFTER THE COVID-19 LOCKDOWN

Ricci F, Fania L, Paradisi A, Di Lella G, Pallotta S, Sobrino L, Panebianco A, Annessi G, Abeni D.



J Eur Acad Dermatol Venereol. 2020 Aug 11. doi: 10.1111/jdv.16874.

Categories: Specific diseases and patient groups

Clinical Characteristics and Outcomes in Patients With COVID-2019 and Leprosy

Santos VS, Quintans-Júnior LJ, de Souza Barboza W, Antunes de Souza Araújo A, Ricardo Martins-Filho P.



J Eur Acad Dermatol Venereol. 2020 Aug 31. doi: 10.1111/jdv.16899.

Categories: Specific diseases and patient groups

Wearing a mask and facial skin diseases: patients with atopic dermatitis express themselves

Stéphanie Merhand, Laurent Misery, Véronique Delvigne, Caroline Le Floch, Charles Taïeb



J Eur Acad Dermatol Venereol. 2020 Aug 31. doi: 10.1111/jdv.16917

Categories: Specific diseases and patient groups

Scabies outbreak during home confinement due to the SARS-CoV-2 pandemic

Martínez-Pallás I, Aldea-Manrique B, Ramírez-Lluch M, Vinuesa-Hernando JM, Ara-Martín M.



J Eur Acad Dermatol Venereol. 2020 Aug 18. doi: 10.1111/jdv.16879.

Categories: Specific diseases and patient groups

Effects of lockdown on health of patients with severe atopic dermatitis treated with dupilumab

Ferrucci SM, Tavecchio S, Favale EM, Angileri L, Riva D, Romagnuolo M, Beretta AE, Marzano AV.



J Eur Acad Dermatol Venereol. 2020 Sep 25. doi: 10.1111/jdv.16955.

Categories: Specific diseases and patient groups

Comment on “Drug reaction with eosinophilia and systemic symptoms syndrome in a patient with COVID-19”: Involvement of herpesvirus reactivations and adverse drug reactions in diverse cutaneous manifestations and overall disease severity of COVID-19



Categories: Specific diseases and patient groups

Immunological and virological profile of children with chilblain-like lesions shows no evident link with SARS-CoV-2

L. Fertitta, A. Welfringer, A. Ouedrani, L. Polivka, S. Chhun, L. Chatenoud, J. Fourgeaud, S. Hadj‐Rabia, S. Temmam, M. Eloit, Sermet‐Gaudelus, C. Bodemer



J Eur Acad Dermatol Venereol. 2020 Oct 3. doi.org/10.1111/jdv.16972

Categories: Specific diseases and patient groups

Diagnosis of hair disorders during the COVID-19 pandemic: An introduction to teletrichoscopy.



Categories: Specific diseases and patient groups

Diagnosis of hair disorders during the COVID-19 pandemic: An introduction to teletrichoscopy.

Randolph, M, Al‐alola A, Tosti A



J Eur Acad Dermatol Venereol. 2020 Oct 12. doi.org/10.1111/jdv.16989

Categories: Specific diseases and patient groups

COVID-19 in patients with cutaneous immune-mediated diseases in The Netherlands: real-world observational data

L.E.M. de Wijs M.M. Joustra J.I. Olydam T. Nijsten D.J. Hijnen



J Eur Acad Dermatol Venereol. 2020 Nov 1 doi.org/10.1111/jdv.17025

Categories: Specific diseases and patient groups

COVID-19 and HHV8 first spotted together: an affair under electron microscopy

E. Leoni M. Cerati G. Finzi M. Lombardo F. Sessa



J Eur Acad Dermatol Venereol. 2021 18 Jan doi.org/10.1111/jdv.17123

Categories: Specific diseases and patient groups

Concerns and perceptions of patients with psoriatic disease during the COVID-19 pandemic: results from a two-wave survey by the National Psoriasis Foundation

G.C. Gondo S.J. Bell J. Slayden G. Ullmann A. Blauvelt



J Eur Acad Dermatol Venereol. 2021 Feb 15 doi.org/10.1111/jdv.17173

Categories: Specific diseases and patient groups

Is SARS-CoV-2 screening test indicated for psoriasis patients candidate to biologic therapy?

S. Piaserico P. Gisondi S. Cazzaniga G. Girolomoni P.G. Calzavara‐Pinton L. Naldi



J Eur Acad Dermatol Venereol. 2021 Feb 15 doi.org/10.1111/jdv.17175

Categories: Specific diseases and patient groups

COVID-19 and immune checkpoint inhibitors

M.S. Ahmed H. Brehme S. Friedrich L. Reinhardt S. Blum S. Beissert F. Meier



J Eur Acad Dermatol Venereol. 2021 Feb 15 doi.org/10.1111/jdv.17172

Categories: Specific diseases and patient groups

RAPIDLY PROGRESSIVE ALOPECIA AREATA TOTALIS IN A COVID-19 PATIENT, UNRESPONSIVE TO TOFACITINIB

S. Berbert Ferreira M.F.R. Gavazzoni Dias R. Berbert Ferreira A.C. Neves Neto R.M. Trüeb O. Lupi



J Eur Acad Dermatol Venereol. 2021 Feb 15 doi.org/10.1111/jdv.17170

Categories: Specific diseases and patient groups

Insights into COVID-19 vaccination in patients with chronic plaque psoriasis on systemic treatments

P. Gisondi D. Geat L. Naldi S. Piaserico



J Eur Acad Dermatol Venereol. 2021 Mar 1 doi.org/10.1111/jdv.17200

Categories: Specific diseases and patient groups

COVID-19 pandemic and autoimmune bullous diseases: A cross-sectional study of the International Pemphigus and Pemphigoid Foundation

M. Kasperkiewicz M. Yale R. Strong D. Zillikens D.T. Woodley A. Recke



J Eur Acad Dermatol Venereol. 2021 Mar 16 doi.org/10.1111/jdv.17228

Categories: Specific diseases and patient groups

Risk of severe allergic reactions to Covid-19 vaccines among patients with allergic or inflammatory skin diseases – practical recommendations. A position statement of ETFAD with external experts

J. Ring M. Worm A. Wollenberg J.P. Thyssen T. Jakob L. Klimek C. Bangert S. Barbarot T. Bieber M.S. de Bruin‐Weller P.V. Chernyshov S. Christen‐Zaech M. Cork U. Darsow C. Flohr R. Fölster‐Holst C. Gelmetti U. Gieler J. Gutermuth A. Heratizadeh D.J. Hijnen L.B. von Kobyletzki B. Kunz C. Paul L. De Raeve J. Seneschal D. Simon P.I. Spuls J.F. Stalder A. Svensson Z. Szalai A. Taieb A. Torrelo M. Trzeciak C. Vestergaard T. Werfel S. Weidinger M. Deleuran



J Eur Acad Dermatol Venereol. 2021 March 22 doi.org/10.1111/jdv.17237

Categories: Specific diseases and patient groups

VACCINATION AGAINST SARS-COV-2 and PSORIASIS: the three things every dermatologist should know

F. Diotallevi A. Campanati G. Radi E. Martina G. Rizzetto P Barbadoro M.M. D’Errico A. Offidani



J Eur Acad Dermatol Venereol. 2021 Mar 29 doi.org/10.1111/jdv.17256

Categories: Specific diseases and patient groups

Incidence and prognosis of COVID-19 in psoriasis patients on biologic therapy: a multicenter retrospective cohort study

Jorge R. Georgakopoulos Asfandyar Mufti Ron Vender Vimal H. Prajapati Jensen Yeung



J Eur Acad Dermatol Venereol. 2021 Apr 19 doi.org/10.1111/jdv.17279

Categories: Specific diseases and patient groups

Penile ischemia secondary to COVID-19: Why should the dermatologist be concerned?

P. Sarkis J. Sarkis M. Alkassis J. Assaf K. El Gharib



J Eur Acad Dermatol Venereol. 2021 Apr 18 doi.org/10.1111/jdv.17287

Categories: Specific diseases and patient groups

Pityriasis rosea, COVID-19 and vaccination: new keys to understand an old acquaintance

JM Busto‐Leis G Servera‐Negre A Mayor‐Ibarguren E Sendagorta‐Cudós M Feito‐Rodríguez A Nuño‐González MD Montero‐Vega P Herranz‐Pinto



J Eur Acad Dermatol Venereol. 2021 Apr 26 doi/abs/10.1111/jdv.17301

Categories: Specific diseases and patient groups

Adamantiades-Behçet’s disease (Behçet’s disease) and COVID-19

C.C. Zouboulis J.A.M. van Laar M. Schirmer G. Emmi F. Fortune A. Gül Y. Kirino E.‐S. Lee P.P. Sfikakis F. Shahram G.R. Wallace



J Eur Acad Dermatol Venereol. 2021 Apr 29 com/doi/10.1111/jdv.17325

Categories: Specific diseases and patient groups

Contemporary occurrence of Chilblain-like lesions and Pityriasis rosea during the COVID-19 pandemic

V. Piccolo, A. Bassi, G. Argenziano, C. Mazzatenta, M. Cutrone, I. Neri, R. Grimalt, T. Russo



J Eur Acad Dermatol Venereol. 2021 May 29 oi/full/10.1111/jdv.17409

Categories: Specific diseases and patient groups

Low incidence rate of respiratory and viral infections over 5 years of treatment with tildrakizumab in patients with moderate-to-severe psoriasis: pooled analysis from reSURFACE 1 and reSURFACE 2 phase 3 trials

D. Thaçi, D. Jullien, A. Egeberg, J.M. Carrascosa, J.J. Wu, I. Pau-Charles, P. Gisondi



J Eur Acad Dermatol Venereol. 2021 May 31 com/doi/10.1111/jdv.17427

Categories: Specific diseases and patient groups

Androgenetic alopecia in women and men is not related to COVID-19 infection severity: A prospective cohort study of hospitalized COVID-19 patients

Shatila Torabi, Mahnaz Mozdourian, Roxana Rezazadeh, Abolfazl Payandeh, Shapour Badiee, Emadodin Darchini-Maragheh



J Eur Acad Dermatol Venereol. 2021 May 12 com/doi/10.1111/jdv.17353

Categories: Specific diseases and patient groups

Patients with Primary Cutaneous Lymphoma are at risk for severe COVID-19. Data from the Spanish Primary Cutaneous Lymphoma Registry

A. Sánchez-Velázquez, A. Bauer-Alonso, T. Estrach, D. Vega-Díez, P. Garcia-Muret, L. Haya, Y. Peñate, E. Acebo, R. Fernández de Misa, M. Blanes, HJ. Suh-Oh, R. Izu, E. Silva-Díaz, J. Sarriugarte, C. Román-Curto, R. Botella-Estrada, A. Mateu-Puchades, L. Prieto-Torres, V. Morillas, Me. Morillo, P. Sanchez-Caminero, L. Calzado, A. Pérez-Ferriols, A. Pérez, JD. Domínguez, M. Navedo, C. Muniesa, A. Combalia, J. Arroyo-Andrés, MA. Descalzo, I. García-Doval, PL. Ortiz-Romero



J Eur Acad Dermatol Venereol. 2021 Jun 1 com/doi/10.1111/jdv.17430

Categories: Specific diseases and patient groups

A review of nail findings associated with COVID-19 infection

Edward Hadeler, Brian W. Morrison, Antonella Tosti



J Eur Acad Dermatol Venereol. 2021 Jun 15 com/doi/10.1111/jdv.17448

Categories: Specific diseases and patient groups

The Significance of Exanthems in COVID-19 Patients Hospitalized at a Tertiary Care Center

R. Rrapi, S. Chand, J.A. Lo, C.K. Gabel, S. Song, Z. Holcomb, C. Iriarte, K. Moore, C.R. Shi, H. Song, F.D. Xia, D. Yanes, R. Gandhi, V.A. Triant, D. Kroshinsky



J Eur Acad Dermatol Venereol. 2021 Jun 19 com/doi/10.1111/jdv.17459

Categories: Specific diseases and patient groups

Ulcus vulvae acutum and SARS-Co V-2: an etiological role?

M.C. Alberelli, A. Panariello, M. Olivi, A. Borghi, P. Zedde, M. Corazza



J Eur Acad Dermatol Venereol. 2021 Jun 21 oi/10.1111/jdv.17463?af=R

Categories: Specific diseases and patient groups

Reduction in the number of early melanomas diagnosed during the COVID-19 pandemic: a single-centre cohort study

Erica Koch, Francisco Villanueva, Michael A. Marchetti, Álvaro Abarzúa-Araya, Consuelo Cárdenas, Juan Camilo Castro, Francisco Dominguez, Katherine Droppelmann, Nicolás Droppelmann, Héctor Galindo, Augusto León, Jorge Madrid, Montserrat Molgó, Sebastián Mondaca, Pablo H. Montero, Pablo Uribe, Miguel A. Villaseca, Eugenio Vinés, Cristian Navarrete-Dechent



J Eur Acad Dermatol Venereol. 2021 Jul 14 oi/full/10.1111/jdv.17522

Categories: Specific diseases and patient groups

Impact of the COVID-19 pandemic on melanoma diagnosis

P. Gisondi, S. Cazzaniga, S. Di Leo, S. Piaserico, F. Bellinato, M. Pizzolato, A. Gatti, A. Eccher, M. Brunelli, D. Saraggi, G. Girolomoni, L. Naldi



J Eur Acad Dermatol Venereol. 2021 Jul 8 com/doi/10.1111/jdv.17493

Categories: Specific diseases and patient groups

The impact of the COVID-19 pandemic on diagnostic delay of skin cancer: a call to restart screening activities

Clio Dessinioti, Claus Garbe, Alexander J Stratigos



J Eur Acad Dermatol Venereol. 2021 Jul 26 com/doi/10.1111/jdv.17552

Categories: Specific diseases and patient groups

COVID-19 and skin diseases: results from a survey of 843 patients with atopic dermatitis, psoriasis, vitiligo and chronic urticaria

P.R. Criado,M. Ianhez,C.C. Silva de Castro,C. Talhari,P.M. Ramos,H.A. Miot



J Eur Acad Dermatol Venereol. 2021 Sep 6 com/doi/10.1111/jdv.17635

Categories: Specific diseases and patient groups

Incidence and prognosis of COVID-19 in patients with psoriasis on apremilast: a multicentre retrospective cohort study

Y. Lytvyn,J.R. Georgakopoulos,A. Mufti,A.R. Devani,M.J. Gooderham,V. Jain,P. Lansang,R. Vender,V.H. Prajapati,J. Yeung



J Eur Acad Dermatol Venereol. 2021 Oct 17 com/doi/10.1111/jdv.17749

Categories: Specific diseases and patient groups

Impact of the French COVID-19 pandemic lockdown on new melanoma diagnosis delay and severity

R. Molinier,A. Roger,B. Genet,A. Blom,C. Longvert,L. Chaplain,M. Fort,P. Saiag,E. Funck-Brentano



jdv.17802

Categories: Specific diseases and patient groups

Immunogenicity and safety of anti-SARS-CoV-2 BNT162b2 vaccine in psoriasis patients treated with biologic drugs.

A. Cristaudo,D. Graceffa,F. Pimpinelli,F. Sperati,G. Spoletini,C. Bonifati,R. Pellini,V. Lora,M. Pontone,O. Di Bella,D. Bracco,A. Morrone



J Eur Acad Dermatol Venereol. 2021 Dec 11 doi.org/10.1111/jdv.17861

Categories: Specific diseases and patient groups

Lack of association between seborrheic dermatitis and SARS-CoV-2 outcomes

U. Rakita,T. Kaundinya,A. Guraya,K. Nelson,B. Maner,J. Manjunath,G. Schwartzman,B. Lane,J.I. Silverberg



J Eur Acad Dermatol Venereol. 2021 Nov 22 doi.org/10.1111/jdv.17825

Categories: Specific diseases and patient groups

Concomitant SARS-CoV-2 infection and crusted scabies in a 4-month infant

A. Giannattasio,M. Rosa,S. Esposito,O. Di Mita,F. Angrisani,S. Acierno,C. D’Anna,F. Barbato,V. Tipo,O. Ametrano



J Eur Acad Dermatol Venereol. 2021 Dec 4 doi.org/10.1111/jdv.17850

Categories: Specific diseases and patient groups

PRIMITIVE MELANOMA AND COVID 19 ARE WE STILL PAYING THE PRICE OF THE PANDEMIC?

F. Ricci,G. Di Lella,L. Fania,F. Ricci,L. Sobrino,S. Pallotta,A. Panebianco,C. Fortes,D. Abeni



J Eur Acad Dermatol Venereol. 2021 Dec 20 doi.org/10.1111/jdv.17892

Categories: Specific diseases and patient groups

High frequency of eosinophilia and viral reactivation in drug hypersensitivity in patients with SARS-CoV-2 infection

B. Mille,S. Ingen-Housz-Oro,N. De Prost,G. Voiriot,A. Soria,F. Tetart,C. Bernier,C. Morice,D. Staumont-Salle,F. Dezoteux,(“French Investigator for Skin Adverse Reaction to Drugs”)



J Eur Acad Dermatol Venereol. 2021 Dec 20 doi.org/10.1111/jdv.17885

Categories: Specific diseases and patient groups

The impact of the COVID-19 pandemic on keratinocyte carcinoma in the Netherlands: trends in diagnoses and magnitude of diagnostic delays

E. Slotman,K. Schreuder,T.E.C. Nijsten,M. Wakkee,L. Hollestein,A. Mooyaart,S. Siesling,M.W.J. Louwman



J Eur Acad Dermatol Venereol. 2022 Jan 28 doi.org/10.1111/jdv.17976

Categories: Specific diseases and patient groups

Clinical improvement of atopic dermatitis in two patients co-affected with non-severe COVID-19 infection: A case series and review of literature

G. Licata,D. Buononato,C. Fiorentino,G. Calabrese,A. De Rosa,G. Argenziano,A. Gambardella



J Eur Acad Dermatol Venereol. 2022 Jan 11 doi.org/10.1111/jdv.17913

Categories: Specific diseases and patient groups

Atopic Dermatitis exacerbation after Covid-19 vaccination in Dupilumab treated patients

L. Potestio,M. Napolitano,L. Bennardo,G. Fabbrocini,C. Patruno



J Eur Acad Dermatol Venereol. 2022 Jan 23 doi.org/10.1111/jdv.17964

Categories: Specific diseases and patient groups

Primary cutaneous lymphoma and risk for severe COVID-19: a prospective study of 48 cases in Morocco

H. Kerrouch,M. Khalidi,R. Frikh,N. Hjira,M. Boui



J Eur Acad Dermatol Venereol. 2022 Mar 12 doi.org/10.1111/jdv.18057

Categories: Specific diseases and patient groups

Moderate-to-severe atopic dermatitis in adolescents treated with dupilumab: A multicentre Italian real-world experience

L. Stingeni,L. Bianchi,E. Antonelli,E.S. Caroppo,S.M. Ferrucci,M. Ortoncelli,G. Fabbrocini,E. Nettis,D. Schena,M. Napolitano,M. Gola,L. Bonzano,M. Rossi,A. Belloni Fortina,A. Balato,K. Peris,C. Foti,F. Guarneri,M. Romanelli,C. Patruno,P. Savoia,M.C. Fargnoli,F. Russo,E. Errichetti,T. Bianchelli,L. Bianchi,G. Pellacani,C. Feliciani,A. Offidani,M. Corazza,G. Micali,N. Milanesi,G. Malara,A. Chiricozzi,M. Tramontana,K. Hansel,DADA – Dupilumab for Atopic Dermatitis of the Adolescence Study Group



J Eur Acad Dermatol Venereol. 2022 Apr 12 doi.org/10.1111/jdv.18141

Categories: Specific diseases and patient groups

Impact of containment and social distancing on the number of community-acquired Staphylococcus aureus skin infections

P. Del Giudice,J. Gillon,L. Roudiere,M. Reverte



J Eur Acad Dermatol Venereol. 2022 Mar 29 doi.org/10.1111/jdv.18111

Categories: Specific diseases and patient groups

Healthcare and safety of patients with melanoma during the COVID-19 Pandemic in Italy

S. Caini,M. Brusasco,G. Niero,V. De Giorgi,M. Lombardo,C. Massone,M. Medri,G. Palmieri,M.A. Pizzichetta,P. Quaglino,R. Satta,C. Feliciani,S. Gandini,I. Stanganelli,Italian Melanoma Intergroup (IMI), Italian Association of Melanoma Patients (AIMaMe)



J Eur Acad Dermatol Venereol. 2022 Mar 12 doi.org/10.1111/jdv.18056